Working bibliography

The evidence, before the episode

Every source checked against a primary record and held against its topic on the map — 135 citations across 82 topics. This is groundwork, not an investigation: nothing here has been through the editorial pass, and a citation appearing on this page is not the show endorsing what it found. 40 topics also carry a blueprint — the spine an episode would follow, written from the sources above it and no further.

Sleep & circadian

Adenosine

Rises through every waking hour, falls in sleep; caffeine blocks its receptors.

1. Reichert CF, Deboer T, Landolt HP. Adenosine, caffeine, and sleep-wake regulation: state of the science and perspectives.J Sleep Res · 2022 · 31(4):e1359710.1111/jsr.13597 · PMID 35575450

   Review. Adenosine is now accepted as an endogenous sleep-regulatory substance and caffeine acts as its receptor antagonist. The authors are careful that a DIRECT role in sleep homeostasis is still argued, and that acute and chronic caffeine differ — worth keeping when the episode is written.

Orexin

Narcolepsy type 1 is the loss of these neurons; the newest sleep drugs block their receptors.

1. Jacobson LH, Hoyer D, de Lecea L. Hypocretins (orexins): The ultimate translational neuropeptides.J Intern Med · 2022 · 291(5):533–55610.1111/joim.13406 · PMID 35043499

   Review. Confirms both halves of the node: loss of hypocretin cells in humans causes narcolepsy type 1 with cataplexy, and that causal link produced a drug class — suvorexant and lemborexant approved for insomnia, daridorexant then filed.

Sleep-onset latency

Minutes between lights out and actual sleep; melatonin trials shorten it by about seven.

1. Ferracioli-Oda E, Qawasmi A, Bloch MH. Meta-analysis: melatonin for the treatment of primary sleep disorders.PLoS One · 2013 · 8(5):e6377310.1371/journal.pone.0063773 · PMID 23691095

   19 trials, 1683 subjects. Sleep latency fell by 7.06 minutes (95% CI 4.37–9.75) — this is the source of the 'about seven minutes' figure. The authors say plainly the absolute benefit is smaller than other insomnia drugs, and argue for melatonin on its side-effect profile rather than its effect size.

2. Yue JL, Chang XW, Zheng JW, et al. Efficacy and tolerability of pharmacological treatments for insomnia in adults: a systematic review and network meta-analysis.Sleep Med Rev · 2023 · 68:10174610.1016/j.smrv.2023.101746 · PMID 36701954

   69 studies, 17,319 patients, 20 drugs ranked. Orexin receptor antagonists came top for sleep latency, wake after sleep onset and sleep efficiency. Useful counterweight: it also states the long-term adverse effects of ALL these medications are unclear.

Suprachiasmatic nucleus

About twenty thousand neurons above the optic chiasm, set by light through the eye.

1. Hastings MH, Smyllie NJ, Patton AP. Molecular-genetic manipulation of the suprachiasmatic nucleus circadian clock.J Mol Biol · 2020 · 432(12):3639–366010.1016/j.jmb.2020.01.019 · PMID 31996314

   Review from the MRC LMB. The SCN is the principal circadian timekeeper of mammals, built on a transcription–translation feedback loop (Per/Cry against Clock/Bmal1) that exists in ALL major tissues — the SCN's job is co-ordinating them, not keeping the only clock. Also flags astrocytes in the SCN network, which is newer than most popular accounts.

Immune

Autoimmunity

In lupus and RA, self-antibodies appear years before symptoms; boosting is the wrong verb.

1. Yamout BI, Alroughani R. Multiple Sclerosis.Semin Neurol · 2018 · 38(2):212–22510.1055/s-0038-1649502 · PMID 29791948

   Review, used here as the worked example of an autoimmune disease rather than as a source on autoimmunity generally — replace with a broader epidemiological source before broadcast. Two things to carry forward: MS prevalence is rising for two different reasons that get conflated (earlier diagnosis and longer survival, AND a true rise in incidence), and the disease is framed as a gene-by-environment interaction rather than either alone.

Common-cold trial design

Every trial defines a cold differently, and few confirm that a virus was there.

1. Hemilä H, Chalker E. Vitamin C for preventing and treating the common cold.Cochrane Database Syst Rev · 2013 · (1):CD00098010.1002/14651858.CD000980.pub4 · PMID 23440782

   The cleanest worked example of why trial DESIGN decides the answer. 29 comparisons, 11,306 people: regular supplementation did not cut cold incidence in the general population (RR 0.97) — but the same vitamin cut incidence by half (RR 0.48) in marathon runners, skiers and soldiers, shortened colds by 8% in adults and 14% in children, and did nothing at all when taken AFTER symptoms began. Prevention versus treatment, and general population versus extreme physical stress, are four different questions.

Helminth immunomodulation

Worm exposure tracks LOWER rates of autoimmune and metabolic disease. The immunology runs opposite to the folklore about parasites.

1. Sipahi AM, Baptista DM. Helminths as an alternative therapy for intestinal diseases.World J Gastroenterol · 2017 · 23(33):6009–601510.3748/wjg.v23.i33.6009 · PMID 28970717

   EDITORIAL, not a trial or a systematic review — treat as orientation only. Its own honest line is the one to keep: there is some evidence on safety and tolerability, but 'evidence about their impact on disease activity is lacking'. Species, dose, timing and mechanism are all still open. This is the cautionary half of the hygiene-hypothesis story.

Immune boosting

Marketing sells a single quantity that no laboratory test actually measures.

1. Hemilä H, Chalker E. Vitamin C for preventing and treating the common cold.Cochrane Database Syst Rev · 2013 · (1):CD00098010.1002/14651858.CD000980.pub4 · PMID 23440782

   The counter-example to 'immune boosting'. Cochrane's own conclusion: routine vitamin C supplementation is NOT justified for the general population. What survives is narrower and more interesting — a duration effect, and a real halving of incidence under severe physical stress. The integrative reading is not 'it works', it is 'it works for a specific person in a specific state', which is a different claim from the one on the bottle.

Innate immunity

Most cold symptoms come from the host response, not from the virus itself.

1. Bekkering S, Blok BA, Joosten LAB, Riksen NP, van Crevel R, Netea MG. In vitro experimental model of trained innate immunity in human primary monocytes.Clin Vaccine Immunol · 2016 · 23(12):926–93310.1128/CVI.00349-16 · PMID 27733422

   IN VITRO, human primary monocytes — a methods paper, not a clinical result. Worth having because it pins down what 'trained immunity' actually means physically: β-glucan, BCG and oxidised LDL all leave monocytes responding harder to unrelated bacteria days later, with a switch to glycolysis. Innate immunity having memory at all is the part that overturns the textbook.

Rhinovirus

More than 150 types circulate, and immunity to one buys little against the rest.

1. Murray CS, Simpson A, Custovic A. Allergens, viruses, and asthma exacerbations.Proc Am Thorac Soc · 2004 · 1(2):99–10410.1513/pats.2306027 · PMID 16113420

   Review, and an old one — replace before broadcast. Kept for the synergy point, which still holds: rhinovirus and allergen exposure together drive asthma exacerbations harder than either alone, which is why 'just a cold' is not just a cold in a sensitised asthmatic.

Gut & microbiome

Bile acids

Detergents that also act as hormones, and gut bacteria rewrite them en route.

1. Jia W, Xie G, Jia W. Bile acid-microbiota crosstalk in gastrointestinal inflammation and carcinogenesis.Nat Rev Gastroenterol Hepatol · 2018 · 15(2):111–12810.1038/nrgastro.2017.119 · PMID 29018272

   Review. The useful frame for this node: bile acids are not just detergents for fat, they are SIGNALS, read by FXR and TGR5, and gut bacteria chemically rewrite them before the host receives them. That makes bile acid metabolism a two-way conversation between liver and microbiome that touches lipid and carbohydrate handling, insulin sensitivity and innate immunity.

Intestinal permeability

Much of the leaky-gut literature rests on a zonulin ELISA that does not measure zonulin.

1. Seethaler B, Basrai M, Neyrinck AM, et al. Biomarkers for assessment of intestinal permeability in clinical practice.Am J Physiol Gastrointest Liver Physiol · 2021 · 321(1):G11–G1710.1152/ajpgi.00113.2021 · PMID 34009040

   The measurement problem, which is the real story under 'leaky gut'. Against the established lactulose/mannitol test in 78 people, plasma LBP tracked permeability in every cohort — but ZONULIN, the marker sold direct to consumers, only correlated in the overweight and obese group, and only when measured in stool. A zonulin result in a lean person is being asked to carry more than this data supports.

Serotonin

Ninety per cent is made in the gut, and that fraction never reaches the brain.

1. Yano JM, Yu K, Donaldson GP, et al. Indigenous bacteria from the gut microbiota regulate host serotonin biosynthesis.Cell · 2015 · 161(2):264–27610.1016/j.cell.2015.02.047 · PMID 25860609

   The landmark, from Mazmanian's lab. Spore-forming gut bacteria drive 5-HT synthesis in colonic enterochromaffin cells, which supply the mucosa, the lumen and circulating platelets — and germ-free mice given the right microbial metabolites raise their colonic and blood serotonin. MOUSE work with human-derived bacteria. The honest framing for air: this is where 'the gut makes most of your serotonin' stops being a slogan and becomes a mechanism, but it is gut serotonin, which does not cross into the brain.

Short-chain fatty acids

Butyrate, propionate, acetate — the cells lining the colon run mostly on the first.

1. Fernando MR, Saxena A, Reyes JL, McKay DM. Butyrate enhances antibacterial effects while suppressing other features of alternative activation in IL-4-induced macrophages.Am J Physiol Gastrointest Liver Physiol · 2016 · 310(10):G822–83110.1152/ajpgi.00440.2015 · PMID 27012776

   MOUSE macrophages in culture — narrow, and a better human source should replace it. Kept for two things it states directly: butyrate comes from bacterial fermentation of dietary fibre and is the PRIMARY energy source of colonocytes, and it acts on immune cells partly by inhibiting histone deacetylation. A fibre metabolite changing gene expression is the mechanism worth an episode.

SIBO

Too many bacteria in the small bowel; the breath test and the culture often disagree.

1. Quigley EMM, Murray JA, Pimentel M. AGA Clinical Practice Update on Small Intestinal Bacterial Overgrowth: Expert Review.Gastroenterology · 2020 · 159(4):1526–153210.1053/j.gastro.2020.06.090 · PMID 32679220

   The AGA's own position, and unusually blunt. 'The definition of SIBO as a clinical entity lacks precision and consistency'; true prevalence is therefore undefined; controversy remains over its role in IBS; and the antibiotic evidence base is thin enough that therapy is 'for the most part, empiric'. It also names the real problem — we do not know what a NORMAL small-intestinal bacterial population looks like, so there is no baseline to call overgrowth against. Anyone selling a SIBO protocol is ahead of this document.

Soluble fibre

Viscous types bind bile acids and lower LDL-C; fermentable types feed the bacteria.

1. Gibb RD, Sloan KJ, McRorie JW. Psyllium is a natural nonfermented gel-forming fiber that is effective for weight loss: a comprehensive review and meta-analysis.J Am Assoc Nurse Pract · 2023 · 35(8):468–47610.1097/JXX.0000000000000882 · PMID 37163454

   READ THE AFFILIATION FIRST. The lead author is at The Procter & Gamble Co., which sells psyllium as Metamucil, and this is a meta-analysis of six studies totalling 354 people concluding their product works. That does not make the result false — the mechanism is real and specific: psyllium is soluble but NOT fermented, so it forms a viscous gel that slows nutrient absorption rather than feeding bacteria, which is the opposite of how most fibre is sold. It does mean the effect sizes (-2.1 kg, -0.8 BMI) need an independent replication before this show quotes them. A useful teaching case: industry authorship is a reason to check, not a reason to dismiss.

Tryptophan

Only a small fraction becomes serotonin; most runs down the kynurenine pathway.

1. Correia AS, Vale N. Tryptophan metabolism in depression: a narrative review with a focus on serotonin and kynurenine pathways.Int J Mol Sci · 2022 · 23(15):849310.3390/ijms23158493 · PMID 35955633

   Narrative review — the weakest review type, so treat as a map rather than evidence. The map itself is the point: one amino acid feeds two pathways that pull in opposite directions, and inflammation shifts the traffic from the serotonin branch toward kynurenine. That is the mechanistic bridge between 'inflammation' and 'low mood' that most popular accounts skip.

Glycemic control

Chromium

Trials are small and concentrated in people who were deficient to start with, and the effect shrinks as the methods get better.

1. Asbaghi O, Naeini F, Rezaei Kelishadi M, et al. Effects of chromium supplementation on glycemic control in patients with type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials.Pharmacol Res · 2020 · 161:10509810.1016/j.phrs.2020.105098 · PMID 32730903

   28 RCTs. Every glycaemic index moved: fasting glucose -19.0 mg/dl, insulin -12.35 pmol/l, HbA1c -0.71%, HOMA-IR -1.53. Then read the heterogeneity: I-squared is 99.8% for fasting glucose and 89.9% for HOMA-IR. At 99.8% the trials are not estimating the same quantity, and a pooled mean across them is close to meaningless — the honest statement is that SOME chromium trials show large effects, not that chromium lowers glucose by 19 mg/dl. This is the single most important caveat on the node, and it is the sort of thing supplement marketing quotes without.

Vanadium

Insulin-mimetic in animals, and toxic at the doses that did it. The clearest example on this map of a mechanism that never became a medicine.

1. Korbecki J, Baranowska-Bosiacka I, Gutowska I, Chlubek D. [Insulin-mimetic property of vanadium compounds].Postepy Biochem · 2016 · 62(1):60–65 · in PolishPMID 28132446

   Review, Polish language, no DOI — find an English primary source before broadcast. The pharmacology is the story and it cuts both ways. Vanadium inhibits protein tyrosine phosphatases, which is genuinely insulin-mimetic: more GLUT-4 at the membrane, more glycogen synthesis, less gluconeogenesis. But the authors state the therapeutic window is VERY NARROW, and that at only a few micromoles the same compounds inhibit cell proliferation and cause apoptosis, necrosis and inflammation. A supplement whose effective dose sits next to its cytotoxic dose is not a supplement.

Zinc

Zinc status tracks glycaemic control and repletion helps the deficient — which is not the same thing as a treatment for diabetes.

1. Wang X, Wu W, Zheng W, et al. Zinc supplementation improves glycemic control for diabetes prevention and management: a systematic review and meta-analysis of randomized controlled trials.Am J Clin Nutr · 2019 · 110(1):76–9010.1093/ajcn/nqz041 · PMID 31161192

   32 placebo-controlled trials, 1700 people, 14 countries, in the AJCN. Fasting glucose -14.15 mg/dl, 2-hour postprandial -36.85, HbA1c -0.55%, HOMA-IR -0.73, and hs-CRP -1.31 mg/l. Better quality than the chromium literature and the subgroup analysis is the useful part: the effect on fasting glucose depended on diabetic status AND on the FORM of zinc, with inorganic salts outperforming. 'Zinc' on a label is not one intervention.

Thyroid

Vitamin E

The thyroid runs on trace elements in balance, not in isolation — selenium, iodine and the antioxidants that protect the gland while it works.

1. Zhou Q, Xue S, Zhang L, Chen G. Trace elements and the thyroid.Front Endocrinol · 2022 · 13:90488910.3389/fendo.2022.904889 · PMID 36353227

   Review. The frame this node exists for: thyroid hormone synthesis depends on several trace elements at once — iodine and selenium first, then iron, zinc, magnesium, manganese and others — and they sit in a DYNAMIC BALANCE where an excess or deficiency of one disturbs the rest. That is why correcting iodine without selenium, or the reverse, can go wrong. The authors are careful that the relationship between trace elements and thyroid disorders 'is still unclear' and needs more work. Vitamin E specifically is NOT covered here and still needs its own source — this is the trace-element scaffolding the vitamin E question hangs off.

Cardiometabolic

Betaine (TMG)

Trimethylglycine donates a methyl group to recycle homocysteine back to methionine — a second route when the folate one is blocked.

1. Lu XT, Wang YN, Mo QW, et al. Effects of low-dose B vitamins plus betaine supplementation on lowering homocysteine concentrations among Chinese adults with hyperhomocysteinemia: a randomized, double-blind, controlled preliminary clinical trial.Eur J Nutr · 2023 · 62(4):1599–161010.1007/s00394-023-03087-y · PMID 36717385

   100 adults, 12 weeks, randomised and double-blind. 400 µg folic acid + 8 mg B6 + 6.4 µg B12 + 1 g betaine cut plasma homocysteine by 10.1% against placebo, and the fall tracked the rise in BOTH folate and betaine — evidence the betaine arm contributed rather than riding on the folate. Two things to keep honest: this was a COMBINATION, so it cannot isolate betaine; and the population was Chinese adults free of mandatory folic acid fortification, so the effect in a fortified country may be smaller. Note also an author affiliation with BYHEALTH, a supplement company.

Hyperhomocysteinaemia

Raised homocysteine tracks clots and strokes. Whether it CAUSES them, or just marks the damage, is still the open question.

1. Lentz SR. Mechanisms of homocysteine-induced atherothrombosis.J Thromb Haemost · 2005 · 3(8):1646–165410.1111/j.1538-7836.2005.01364.x · PMID 16102030

   Review, and admirably direct about the thing most coverage skips: raised homocysteine is a risk factor for cardiovascular disease, stroke and VENOUS THROMBOEMBOLISM, but 'it is still uncertain whether hyperhomocysteinemia is a causative factor or a marker of vascular disease'. The causal evidence is strongest in ANIMAL models. The mechanism, where it has been worked out, is endothelial: less bioavailable nitric oxide, either through oxidative inactivation or through inhibition of NO synthase by ADMA, plus thiolation of plasma and endothelial proteins and endoplasmic-reticulum stress driving inflammation and apoptosis. Read alongside the B12 node, where LOWERING homocysteine did not lower events — the two together are the whole argument.

Mood & neurochemistry

Abeta*56

The 2006 oligomer that shaped a field. The paper was retracted in 2024 after its images were found to have been altered.

1. Lesné S, Koh MT, Kotilinek L, et al. A specific amyloid-beta protein assembly in the brain impairs memory. [RETRACTED]Nature · 2006 · 440(7082):352–357 · retracted 202410.1038/nature04533 · PMID 16541076

   PubMed itself classifies this paper as a Retracted Publication — that is checkable in one click and is how the episode should source the claim, rather than by citing journalism about it. The original claim: a 56-kDa soluble assembly, Abeta*56, purified from Tg2576 mouse brain impaired memory in young rats INDEPENDENTLY of plaques or neuron loss. It ran for 16 years and shaped a field. Retracted in 2024 after image alteration. Precision matters here: what was retracted is this specific oligomer result, not the existence of amyloid plaques, which have been observable pathology since 1906.

GSK-3beta

The enzyme joining lithium, insulin signalling and tau phosphorylation — and the least famous node on this map.

1. Duthie A, et al. Pilot Trial of Lithium in Humans With Mild Cognitive Impairment (GSK-3 target engagement).Front Mol Neurosci · 2019 · 12:16310.3389/fnmol.2019.00163 · PMID 31316348

Kynurenine pathway

Inflammation induces IDO, which pulls tryptophan away from serotonin.

1. Correia AS, Vale N. Tryptophan metabolism in depression: a narrative review with a focus on serotonin and kynurenine pathways.Int J Mol Sci · 2022 · 23(15):849310.3390/ijms23158493 · PMID 35955633

   Narrative review. Places the kynurenine branch at the junction of neuroinflammation, stress, the microbiota and BDNF regulation. Needs primary trial evidence alongside it before any claim that shifting this pathway changes symptoms.

Low-dose lithium

Doses far below the psychiatric range inhibit GSK-3 and track lower dementia rates. The trials so far are small, and two of them disagree.

1. Forlenza OV, Coutinho AMN, Aprahamian I, et al. Long-term lithium treatment reduces glucose metabolism in the cerebellum and hippocampus of nondemented older adults: an [18F]FDG-PET study.ACS Chem Neurosci · 2014 · 5(6):484–48910.1021/cn5000315 · PMID 24730717

   RCT, 4 years low-dose lithium in amnestic MCI. Found REDUCED regional glucose metabolism — an awkward result for the neuroprotection story, and the reason this is not a clean win.

2. Duthie A, van Aalten L, MacDonald C, et al. Recruitment, Retainment, and Biomarkers of Response; A Pilot Trial of Lithium in Humans With Mild Cognitive Impairment.Front Mol Neurosci · 2019 · 12:16310.3389/fnmol.2019.00163 · PMID 31316348

   Well tolerated; GSK-3 biomarkers did not move — authors suggest the dose may have been too low to engage the target.

3. Elefante C, Brancati GE, Torrigiani S, et al. Bipolar Disorder and Manic-Like Symptoms in Alzheimer's, Vascular and Frontotemporal Dementia: A Systematic Review.Curr Neuropharmacol · 2023 · 21(12):2516–254210.2174/1570159X20666220706110157 · PMID 35794767

   Systematic review noting low-dose lithium may exert neuroprotective activity in AD.

4. Kessing LV, Gerds TA, Knudsen NN, et al. Association of lithium in drinking water with the incidence of dementia.JAMA Psychiatry · 2017 · 74(10):1005–101010.1001/jamapsychiatry.2017.2362 · PMID 28832877

   73,731 dementia cases against 733,653 matched controls in Denmark — and the shape of the result is the story. It is NOT a dose-response line. Against 2.0–5.0 µg/L, dementia was LOWER above 15.0 µg/L (IRR 0.83) but HIGHER at 5.1–10.0 µg/L (IRR 1.22). A U-shape that turns the wrong way in the middle is what confounding usually looks like, and the authors say outright that confounding from other things associated with municipality of residence cannot be excluded. Use this as the evidence that the QUESTION is serious, not as evidence that lithium in water prevents dementia.

Nitrous oxide

It oxidises the cobalt atom at the centre of vitamin B12 and switches the vitamin off. Your blood level can look completely normal while the spinal cord is failing.

1. Mair D, Paris A, Zaloum SA, White LM, Dodd KC, Englezou C, Patel F, Abualnaja S, Lilleker JB, Gosal D, Hayton T, Liang D, Allroggen H, Pucci M, Keddie S, Noyce AJ. Nitrous oxide-induced myeloneuropathy: a case series.J Neurol Neurosurg Psychiatry · 2023 · 94(9):681–68810.1136/jnnp-2023-331131 · PMID 37253616

   119 patients across London, Birmingham and Manchester — the largest series to date. Pins and needles was the presenting complaint in 85%, lower limbs before upper; gait ataxia common; bladder and bowel involvement frequent. The cord lesion sits at C3–C5 on T2 imaging. Canisters consumed per week correlated with methylmalonic acid (ρ=0.44), which is the functional B12 marker — and the reason a normal serum B12 does not exclude this.

2. Xiang Y, Li L, Ma X, Li S, Xue Y, Yan P, Chen M, Wu J. Recreational nitrous oxide abuse: prevalence, neurotoxicity, and treatment.Neurotox Res · 2021 · 39(3):975–98510.1007/s12640-021-00352-y · PMID 33770366

   The review that frames the public health side: rising recreational use in adolescents and young adults, most of whom have no idea of the risk. Stopping and replacing B12 early gives a good prognosis; long-term use without treatment ends in irreversible neurological damage. The mechanism is still argued over, which is worth saying out loud.

Saffron

Seven randomised trials put it level with fluoxetine for mild-to-moderate depression. It is also the most adulterated spice on earth.

1. Yang X, Chen X, Fu Y, Luo Q, Du L, Qiu H, Qiu T, Zhang L, Meng H. Comparative efficacy and safety of Crocus sativus L. for treating mild to moderate major depressive disorder in adults: a meta-analysis of randomized controlled trials.Neuropsychiatr Dis Treat · 2018 · 14:1297–130510.2147/NDT.S157550 · PMID 29849461

   Seven RCTs. Against placebo, SMD -1.22 (95% CI -1.94 to -0.49) — a large effect. Against synthetic antidepressants, SMD 0.16 (-0.25 to 0.57), which is the statistical way of saying no detectable difference. Remission, response and drop-out rates all comparable. The authors rate overall study quality as MODERATE and note moderate heterogeneity, and almost every trial is small and Iranian; that is the thing to check before this becomes an episode, not the effect size.

2. Lopresti AL, Drummond PD. Saffron (Crocus sativus) for depression: a systematic review of clinical studies and examination of underlying antidepressant mechanisms of action.Hum Psychopharmacol · 2014 · 29(6):517–52710.1002/hup.2434 · PMID 25384672

   The review that catalogues dosages, extract sources and standardisation alongside the effect — which is the part that matters for a spice sold by the gram. Proposed mechanisms are serotonergic, antioxidant, anti-inflammatory and neuroendocrine, i.e. four plausible stories rather than one demonstrated one.

Tau

Tangles track cognitive decline better than plaques do, which has always been an awkward fact for the amyloid story.

1. De-Paula VJ, Radanovic M, Diniz BS, Forlenza OV. Alzheimer's disease.Subcell Biochem · 2012 · 65:329–35210.1007/978-94-007-5416-4_14 · PMID 23225010

   Standard review, useful for defining terms on air without jargon. Two hallmarks, two different proteins: neuritic PLAQUES are extracellular amyloid-beta; neurofibrillary TANGLES are intracellular, and are cytoskeletal damage caused by hyperphosphorylation of the microtubule-associated protein tau. Conflating them is the commonest error in popular coverage. Also lays out the three clinical phases — pre-symptomatic, pre-dementia, dementia — which is why 'early intervention' arguments carry so much weight.

The amyloid cascade

Thirty years of drug development aimed at plaques. The plaques are real and visible; that they are the CAUSE is the part still contested.

1. Høilund-Carlsen PF, Revheim ME, Costa T, et al. Passive Alzheimer's immunotherapy: a promising or uncertain option?Ageing Res Rev · 2023 · 90:10199610.1016/j.arr.2023.101996 · PMID 37414156

   The serious, peer-reviewed challenge — and far stronger ground than 'the plaques were made up'. Reviewing RCTs of eight anti-amyloid antibodies, the authors argue the fall in amyloid PET signal is UNLIKELY to be a one-to-one measure of amyloid removal, and may instead reflect therapy-related brain damage, pointing to the raised incidence of ARIA and the reported loss of brain volume. They call on the FDA to PAUSE existing and new approvals pending phase 4 data. George Perry is among the authors. This is the citation for a critical episode; the retraction of Abeta*56 is a separate and narrower point.

Micronutrients

Allithiamine (TTFD)

Fat-soluble thiamine crosses membranes the water-soluble salt cannot. The real question is who is actually deficient, not who feels tired.

1. Várkonyi T, Körei A, Putz Z, et al. Advances in the management of diabetic neuropathy.Minerva Med · 2017 · 108(5):419–43710.23736/S0026-4806.17.05257-0 · PMID 28541026

   CAREFUL: this reviews BENFOTIAMINE, a different lipid-soluble thiamine derivative from allithiamine/TTFD. It is here for the mechanism the two share and for the fact that a derivative was needed at all — benfotiamine activates transketolase and thereby diverts glucose away from the polyol, hexosamine, protein-kinase-C and advanced-glycation pathways. That is the pharmacological case for the derivatives over plain thiamine. Do not let the episode slide from benfotiamine evidence to allithiamine claims; TTFD needs its own trials cited.

Creatine

One of the few supplements where the strength data are solid and the brain data are not.

1. Watson G, Casa DJ, Fiala KA, et al. Creatine use and exercise heat tolerance in dehydrated men.J Athl Train · 2006 · 41(1):18–29PMID 16619091

   THE DEHYDRATION PREMISE DOES NOT SURVIVE THIS ONE EITHER, and the episode has to say so before it says anything else. Double-blind randomised crossover, deliberately hostile conditions: trained men took 21.6 g/day for a week, were dehydrated by 2% of body mass, then exercised 80 minutes at 33.5 C. No difference from placebo in core temperature, heart rate, blood pressure, lactate, thirst, perceived exertion, plasma or urine osmolality, or symptom scores. Conclusion: short-term creatine 'did not increase the incidence of symptoms or compromise hydration status or thermoregulation'. Twelve men, short-term, so it is not the last word — but it is directly on the claim. A sceptical creatine episode is still available; it just cannot be built on dehydration.

Folic acid vs folate

Not the same molecule. The synthetic form needs a reduction step many people run slowly, and it can mask a B12 deficiency while the nerves keep going.

1. Ismail S, Eljazzar S, Ganji V. Intended and unintended benefits of folic acid fortification — a narrative review.Foods · 2023 · 12(8):161210.3390/foods12081612 · PMID 37107407

   Narrative review of ~60 reports since US mandatory fortification began in 1998. It names BOTH halves without flinching. Intended benefit: fewer neural tube defects. Unintended benefits: less anaemia, lower homocysteine, lower cardiovascular risk. And the potential harms, in the authors' own list — unmetabolised folic acid circulating in the blood, increased cancer risk, and MASKING OF VITAMIN B12 DEFICIENCY. That last one is the clinically dangerous one: the anaemia resolves while the neurological damage continues. Note this is about the synthetic form specifically, which is the distinction the episode turns on.

Homocysteine

B vitamins lower it reliably; the trials found no drop in heart attacks or deaths.

1. Langan RC, Goodbred AJ. Vitamin B12 deficiency: recognition and management.Am Fam Physician · 2017 · 96(6):384–389PMID 28925645

   Carries the negative result that matters for this node: giving B12 to people with raised homocysteine and cardiovascular disease does NOT reduce myocardial infarction or stroke, and does not alter cognitive decline. Homocysteine is a real marker of B-vitamin status; lowering the number is not the same as lowering the risk it marks. A clean worked example of a surrogate endpoint failing.

Inositol

Myo- and D-chiro-inositol shift insulin resistance and ovulation in PCOS trials — one of the few supplements with both a mechanism and a signal.

1. Greff D, Juhász AE, Váncsa S, et al. Inositol is an effective and safe treatment in polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled trials.Reprod Biol Endocrinol · 2023 · 21(1):1010.1186/s12958-023-01055-z · PMID 36703143

   26 RCTs, 1691 women. The strongest integrative result in this set: inositol raised the chance of a regular cycle 1.79-fold over placebo and was NON-INFERIOR to metformin, the gold-standard insulin sensitiser, while also lowering BMI, free and total testosterone, androstenedione, glucose and insulin AUC and raising SHBG. The clinical argument is the side-effect profile — metformin's gastrointestinal effects are why people stop taking it. Note what this does NOT show: no fertility or live-birth outcome, and 'non-inferior' is not 'better'.

Magnesium

Blood holds about 1% of the body's supply, so a normal serum level rules out little.

1. Zhang X, Li Y, Del Gobbo LC, et al. Effects of magnesium supplementation on blood pressure: a meta-analysis of randomized double-blind placebo-controlled trials.Hypertension · 2016 · 68(2):324–33310.1161/HYPERTENSIONAHA.116.07664 · PMID 27402922

   34 double-blind placebo-controlled trials, 2028 adults, in Hypertension. Median 368 mg/day for three months lowered systolic BP by 2.00 mmHg and diastolic by 1.78 mmHg. Real, replicated, and SMALL — roughly a tenth of what a first-line antihypertensive does, which is the honest way to present it rather than as either useless or a substitute. One author is at the Center for Magnesium Education and Research, worth noting. The authors themselves flag residual heterogeneity and call for better trials.

Omega-3 (EPA/DHA)

Prescription EPA cut cardiac events; the same dose off a shelf has not been shown to.

1. Jia X, Kohli P, Virani SS. Omega-3 fatty acid and cardiovascular outcomes: insights from recent clinical trials.Curr Atheroscler Rep · 2019 · 21(1):110.1007/s11883-019-0763-0 · PMID 30631963

   Why 'fish oil' is not one question. Reading REDUCE-IT alongside ASCEND and VITAL, the authors conclude the benefit tracks FORMULATION and DOSE: high-dose PURE eicosapentaenoic acid reduced atherosclerotic events where mixed EPA/DHA preparations at ordinary doses did not. A trial of a 4 g pure-EPA prescription drug says nothing about a 1 g supermarket capsule, and both get reported as 'omega-3'.

Pyridoxine (B6)

The vitamin that reliably causes harm: at supplement doses pyridoxine causes a sensory neuropathy that is regularly missed for months.

1. Reddy P. Preventing vitamin B6-related neurotoxicity.Am J Ther · 2021 · 29(6):e637–e64310.1097/MJT.0000000000001460 · PMID 36608063

   The most direct support in this whole set for the 'synthetic form can harm you' argument, and it is specific rather than sweeping. B6 is six vitamers; only pyridoxal 5'-phosphate (PLP) is biologically active. The author states the therapeutic index is NARROW, that supraphysiologic daily dosing risks neurotoxicity above roughly 100 nmol/L, and that PLP-based supplements are PREFERRED OVER PYRIDOXINE because pyridoxine showed more neurotoxicity in neuronal viability testing. Because B6 metabolites are long-lived he recommends WEEKLY 50–100 mg rather than daily. Note the honest hedge the episode must keep: the author also says the pyridoxine–neuropathy association 'is not well established'.

Thiamine (B1)

Metformin inhibits the transporter that absorbs it; the clinical evidence is thinner.

1. Sinha S, Kataria A, Kolla BP, Thusius N, Loukianova LL. Wernicke encephalopathy — clinical pearls.Mayo Clin Proc · 2019 · 94(6):1065–107210.1016/j.mayocp.2019.02.018 · PMID 31171116

   Mayo Clinic Proceedings, and quietly damning about ordinary practice. The classic triad — confusion, eye signs, gait — is complete in only 10% of cases, and only a few cases are diagnosed BEFORE DEATH. Untreated, about 80% go on to Korsakoff syndrome. Their recommendation is that overdiagnosis and overtreatment are preferable given thiamine's excellent safety profile. Also worth saying on air: alcohol is the commonest cause in the US but hyperemesis gravidarum, bowel obstruction and malignancy all do it too, which is how it gets missed.

Vitamin B12

Metformin lowers its absorption, and the deficiency mimics the neuropathy of diabetes.

1. Langan RC, Goodbred AJ. Vitamin B12 deficiency: recognition and management.Am Fam Physician · 2017 · 96(6):384–389PMID 28925645

   No DOI on this one. Practical and specific about who is actually at risk: gastric or small-bowel resection, IBD, METFORMIN for more than four months, PPIs or H2 blockers for more than twelve, vegans and strict vegetarians, and anyone over 75. Two things worth saying on air: serum B12 alone is unreliable, and methylmalonic acid is what confirms deficiency at low-normal levels; and ORAL high-dose B12 (1–2 mg daily) matches intramuscular for correcting both anaemia and neurological symptoms, which contradicts the received wisdom that injections are necessary.

Vitamin D

The VITAL trial gave 25,871 adults 2000 IU daily; cancer and heart events did not move.

1. Christakos S, Dhawan P, Verstuyf A, Verlinden L, Carmeliet G. Vitamin D: metabolism, molecular mechanism of action, and pleiotropic effects.Physiol Rev · 2016 · 96(1):365–40810.1152/physrev.00014.2015 · PMID 26681795

   Physiological Reviews, and it settles the 'vitamin D is a hormone' point on the mechanism rather than on rhetoric. 1,25(OH)2D3 is described as the HORMONALLY ACTIVE form; it works by binding a nuclear receptor (VDR) that heterodimerises with RXR and binds DNA directly, regulating genes many kilobases from the transcription start site. That is a steroid hormone's mode of action, not a cofactor's. Also names CYP2R1 as the principal 25-hydroxylase and notes that inactivating CYP24A1 mutations probably cause idiopathic infantile hypercalcaemia — evidence that this system can be dangerous when dysregulated.

Vitamin D as a hormone

Vitamin D is not a vitamin. It is a secosteroid hormone acting through a nuclear receptor — which is why 'just take more' is the wrong frame.

1. Christakos S, Dhawan P, Verstuyf A, Verlinden L, Carmeliet G. Vitamin D: metabolism, molecular mechanism of action, and pleiotropic effects.Physiol Rev · 2016 · 96(1):365–40810.1152/physrev.00014.2015 · PMID 26681795

   Calcitriol is 1,25(OH)2D3, the end of the activation chain and the molecule that actually does the work through VDR/RXR. Extraskeletal effects reported in knockout and transgenic mice — cancer progression, cardiovascular, immunomodulation in autoimmune disease — with the authors noting only that SOME have also been observed in humans. The gap between mouse mechanism and human outcome is the whole vitamin D supplement debate.

Vitamin K2

Matrix Gla protein needs it for carboxylation; trials show no slower calcification.

1. Diederichsen ACP, Lindholt JS, Möller S, et al. Vitamin K2 and D in patients with aortic valve calcification: a randomized double-blinded clinical trial.Circulation · 2022 · 145(18):1387–139710.1161/CIRCULATIONAHA.121.057008 · PMID 35465686

   A clean NULL in Circulation, and the most instructive result in this batch. 365 men, 720 µg MK-7 plus vitamin D or placebo, two years. Aortic valve calcification progressed by 275 AU on treatment versus 292 on placebo — no difference. No difference in valve area, jet velocity, aortic or coronary calcification, surgery, death or cardiovascular events. AND YET the biomarker worked exactly as the theory predicted: dp-ucMGP fell sharply on MK-7. The carboxylation mechanism is real; the disease did not care. Anyone selling K2 for arterial calcification has to answer this trial.

Lipids

Statins and dementia

Thirty-six cohorts point the other way from the rumour — less dementia on statins, not more. Observational, so read it carefully.

1. Olmastroni E, Molari G, De Beni N, et al. Statin use and risk of dementia or Alzheimer's disease: a systematic review and meta-analysis of observational studies.Eur J Prev Cardiol · 2022 · 29(5):804–81410.1093/eurjpc/zwab208 · PMID 34871380

   This is the opposite of what the node was expected to show, and it has to be said that way round. 36 studies: statin users had LOWER dementia risk (OR 0.80, 0.75–0.86) and lower Alzheimer's risk (OR 0.68, 0.56–0.81), with no difference between men and women and none between lipophilic and hydrophilic statins. The authors' own conclusion is 'the absence of a neurocognitive risk'. The caveat is the whole design: these are OBSERVATIONAL, so healthy-user bias and confounding by indication are live — people well enough to be prescribed and to keep taking a preventive drug are not comparable to people who are not. The authors call for purpose-built RCTs. No episode should present this as proof of neuroprotection.

2. Rojas-Fernandez CH, Cameron JCF. Is statin-associated cognitive impairment clinically relevant? A narrative review and clinical recommendations.Ann Pharmacother · 2012 · 46(4):549–55710.1345/aph.1Q620 · PMID 22474137

   The other half, and the reason the rumour exists. Reports of statin-associated cognitive impairment come mainly from case reports and series; ONE RCT found simvastatin impaired some measures against placebo, while most RCTs and observational studies found a neutral or beneficial effect. Practical and testable: a trial discontinuation can reveal a temporal relationship, and switching from a lipophilic statin to a hydrophilic one (pravastatin, rosuvastatin, which cross the blood-brain barrier less) may resolve it. Their bottom line is that the effect is rare and does not justify changing practice.

Longevity & NAD

Glycine

Made in the body but not always in enough: shortfalls show up in glutathione, collagen — and in homocysteine.

1. Holeček M. Glycine as a conditionally essential amino acid and its relationship to l-serine.Metabolism · 2025 · 170:15633010.1016/j.metabol.2025.156330 · PMID 40527450

   Recent review, and it connects three of this map's nodes in one sentence: glycine deficiency raises HOMOCYSTEINE, alongside impaired synthesis of glutathione, collagen, nucleotides and one-carbon units. Deficiency states listed are ordinary ones — low protein intake, malnutrition, late pregnancy, diabetes, insulin resistance, xenobiotic load. The practical argument is the interesting part: because serine hydroxymethyltransferase links the two, the author argues glycine should be co-administered with L-SERINE rather than given alone, to avoid losing methylenetetrahydrofolate to the SHMT flux and to avoid ammonia from the glycine cleavage system. He also states plainly that no study has compared glycine alone against glycine plus serine, and that controlled studies in people WITHOUT deficiency are still needed.

Glycine:methionine ratio

Muscle meat is rich in methionine and poor in glycine; skin, bone and connective tissue carry the balance. The ratio, not the protein, may be what matters.

1. Holeček M. Glycine as a conditionally essential amino acid and its relationship to l-serine.Metabolism · 2025 · 170:15633010.1016/j.metabol.2025.156330 · PMID 40527450

   Placeholder while the ratio itself is sourced. This review supplies the glycine half — that glycine is only CONDITIONALLY essential, that deficiency is common in ordinary metabolic states, and that one of its consequences is raised homocysteine, which is where methionine metabolism ends up when the recycling routes are short. Still needed before an episode: the methionine-restriction lifespan literature, and human data on whether shifting the dietary ratio changes anything measurable.

Hydrogen water

A gas dissolved in water at millimolar concentrations, with small positive trials and an unresolved question about how something that inert does anything at all.

1. LeBaron TW, Singh RB, Fatima G, Kartikey K, Sharma JP, Ostojic SM, Gvozdjakova A, Kura B, Noda M, Mojto V, Niaz MA, Slezak J. The effects of 24-week, high-concentration hydrogen-rich water on body composition, blood lipid profiles and inflammation biomarkers in men and women with metabolic syndrome: a randomized controlled trial.Diabetes Metab Syndr Obes · 2020 · 13:889–89610.2147/DMSO.S240122 · PMID 32273740

   Sixty people, randomised, double-blinded, placebo-controlled, 24 weeks, >5.5 mmol of H2 per day. Reductions in cholesterol, glucose and HbA1c against placebo, with improved inflammation and redox markers. Longer and better-designed than most of this literature — and still sixty people at one site, with several authors affiliated to a molecular hydrogen institute, which is a declared interest rather than a hidden one but belongs in the reading.

Botanicals & extracts

Crocin

The carotenoid that makes saffron red and most of what a standardised extract is standardised to.

1. Lopresti AL, Drummond PD. Saffron (Crocus sativus) for depression: a systematic review of clinical studies and examination of underlying antidepressant mechanisms of action.Hum Psychopharmacol · 2014 · 29(6):517–52710.1002/hup.2434 · PMID 25384672

   Crocin and safranal are the two constituents the antidepressant work keeps pointing at, and the constituents commercial extracts are standardised against. Same structural problem as curcumin: a brightly coloured, poorly absorbed plant pigment with a large in-vitro literature and a much smaller human one.

Lemon balm

It inhibits the enzyme that clears GABA — the same target as an epilepsy drug. Whether that survives a cup of tea is the question.

1. Awad R, Muhammad A, Durst T, Trudeau VL, Arnason JT. Bioassay-guided fractionation of lemon balm (Melissa officinalis L.) using an in vitro measure of GABA transaminase activity.Phytother Res · 2009 · 23(8):1075–108110.1002/ptr.2712 · PMID 19165747

   A real, named mechanism rather than 'calming': the methanol extract inhibits GABA transaminase, the enzyme that breaks GABA down. Rosmarinic acid is the main active — 40% inhibition at 100 µg/mL, and about 1.5% of the dry leaf. GABA-T is the target of vigabatrin, a licensed anticonvulsant, so this is a herb and a drug aiming at the same enzyme. The gap is everything between an in-vitro rat-brain assay and a human who drank tea.

Thujone

Blamed for a century of absinthe madness. Measured in preserved pre-ban bottles, there was never enough of it to matter.

1. Lachenmeier DW. [Thujone-attributable effects of absinthe are only an urban legend — toxicology uncovers alcohol as real cause of absinthism].Med Monatsschr Pharm · 2008 · 31(3):101–106PMID 18429531

   The dose-response argument, stated plainly: thujone is present in both modern and historic pre-ban absinthe at concentrations so low that a pharmacological effect can be excluded outright. Absinthism, as described in 1890s France, is explained by chronic alcohol misuse alone. The author's warning is worth keeping — blaming thujone trivialises the alcohol.

2. Lachenmeier DW, Nathan-Maister D, Breaux TA, Kuballa T. Long-term stability of thujone, fenchone, and pinocamphone in vintage preban absinthe.J Agric Food Chem · 2009 · 57(7):2782–278510.1021/jf803975m · PMID 19256492

   The obvious objection to measuring century-old bottles is that the thujone might have degraded. It did not: green glass blocked the light, samples reanalysed years apart were unchanged, and only clear-glass storage under UV lost any (18%). The historical measurement stands.

Wormwood

A herb famous for a psychosis it does not cause, with a small steroid-sparing trial in Crohn's that nobody has replicated.

1. Omer B, Krebs S, Omer H, Noor TO. Steroid-sparing effect of wormwood (Artemisia absinthium) in Crohn's disease: a double-blind placebo-controlled study.Phytomedicine · 2007 · 14(2–3):87–9510.1016/j.phymed.2007.01.001 · PMID 17240130

   Forty patients across five German sites, tapered off steroids over ten weeks. 13 of 20 on wormwood reached near-complete symptom remission and held it to week 20; 16 of 20 on placebo needed steroids restarted. That is a striking result in a disease with few steroid-sparing options — and it is forty people, in one trial, from 2007, never replicated. Treat it as the reason to run a bigger trial, not as a reason to take it.

Minerals & iron

Magnesium glycinate

The glycine half is the interesting half — it is the part with a route to homocysteine. The autism claim is weaker than it sounds.

1. Nye C, Brice A. Combined vitamin B6-magnesium treatment in autism spectrum disorder.Cochrane Database Syst Rev · 2005 · (4):CD00349710.1002/14651858.CD003497.pub2 · PMID 16235322

   THE AUTISM PREMISE DOES NOT SURVIVE THIS. Cochrane found three randomised studies, 33 people in TOTAL. One gave no usable data. One found no difference from placebo on social interaction, communication, compulsivity, impulsivity or hyperactivity. The third, eight children selected for features resembling pyridoxine-dependent epilepsy, found an IQ gain of 5.2 points (CI 0.2–10.3) — a confidence interval that nearly touches zero, in eight children. Cochrane's verdict: 'no recommendation can be advanced'. Note also this is B6 PLUS magnesium, where magnesium was added to blunt B6's side effects — not magnesium glycinate, and not magnesium alone. The honest episode says the idea has been tested and the tests were too small to conclude anything, which is different from saying it failed. The homocysteine half of this node is the stronger half: glycine deficiency raises homocysteine (see the glycine node), and glycinate is a glycine salt.

Sickle cell disease

The mutation that protects against malaria does not protect against its cousin — and the spleen that would clear it has usually stopped working by age five.

1. Beri D, Rodriguez M, Singh M, McLaughlin D, Liu Y, Zhong H, Mendelson A, An X, Manwani D, Yazdanbakhsh K, Lobo CA. Babesiosis and sickle red blood cells: loss of deformability, altered osmotic fragility, and hypervesiculation.Blood · 2025 · 145(19):2202–221310.1182/blood.2024027602 · PMID 39869831

   Read from the sickle cell side this is a paper about membranes. The SS red cell is already rigid, already fragile, already shedding vesicles; a parasite that remodels the membrane to get in and out lands on a cell with no reserve. Pair it with the transfusion cases: both the route in and the tissue it lands on are worse in sickle cell disease than anywhere else.

2. Cursino-Santos JR, Singh M, Senaldi E, Manwani D, Yazdanbakhsh K, Lobo CA. Altered parasite life-cycle processes characterize Babesia infection in human sickle cell anemia.Haematologica · 2019 · 104(11):2189–219910.3324/haematol.2018.214304 · PMID 30923098

   The evolutionary frame for the sickle cell node: haemoglobin S is the textbook case of balanced polymorphism — one copy protects against malaria, two copies cause disease. This paper tests whether that protection generalises to Babesia and finds it does not transfer to the trait. Explain balanced polymorphism plainly when this runs; it is the single most elegant idea in human genetics and it is usually taught badly.

Environment & exposure

Fluoride

The most-swallowed drug never prescribed: added to water at 0.7 mg/L, and the contemporary caries benefit measures about a quarter of a tooth.

1. Iheozor-Ejiofor Z, Walsh T, Lewis SR, Riley P, Boyers D, Clarkson JE, Worthington HV, Glenny AM, O'Malley L. Water fluoridation for the prevention of dental caries.Cochrane Database Syst Rev · 2024 · 10:CD01085610.1002/14651858.CD010856.pub3 · PMID 39362658

   THE central document and the one almost nobody quotes accurately. 157 studies, ALL non-randomised, every one downgraded for risk of bias. Contemporary evidence (post-1975, i.e. after fluoride toothpaste became universal): starting fluoridation changes dmft by 0.24 teeth (95% CI -0.03 to 0.52) — roughly a QUARTER OF ONE TOOTH, low certainty, and the confidence interval includes no benefit at all. Caries-free children: 4 percentage points (primary), 3 points (permanent), both CIs crossing zero. Cessation: very low certainty, cannot say. No eligible study reports caries outcomes in ADULTS at all. Harms, from the 2015 arm: at 0.7 ppm about 12% have fluorosis of aesthetic concern (95% CI 8-17%, 40 studies, 59,630 people) and about 40% have fluorosis of any level (90 studies, 180,530 people). That is the honest trade — a quarter of a tooth against a two-in-five chance of marking the enamel.

2. Yeh CH, Wang YL, Vo TTT, Lee YC, Lee IT. Fluoride in Dental Caries Prevention and Treatment: Mechanisms, Clinical Evidence, and Public Health Perspectives.Healthcare (Basel) · 2025 · 13(17):224610.3390/healthcare13172246 · PMID 40941599

   A pro-fluoride narrative review, useful precisely because it concedes the shape of the problem: study heterogeneity, protocol variation, fluorosis, and 'possible neurodevelopmental effects' named as persistent uncertainties. Also the cleanest statement that emerging alternatives — nano-hydroxyapatite, bioactive glass, probiotics — are 'promising but currently supported by limited clinical data'.

Fluoride & cognition

Seventy-four studies, a federal court, and one number that keeps moving: where does the dose-response actually start?

1. Taylor KW, Eftim SE, Sibrizzi CA, Blain RB, Magnuson K, Hartman PA, Rooney AA, Bucher JR. Fluoride Exposure and Children's IQ Scores: A Systematic Review and Meta-Analysis.JAMA Pediatr · 2025 · 179(3):282–29210.1001/jamapediatrics.2024.5542 · PMID 39761023

   The National Toxicology Program's own meta-analysis, and the single most important number in the fluoride debate. 74 studies, 10 of them cohorts. Pooled SMD -0.45 (95% CI -0.57 to -0.33). Individual-level data: IQ falls 1.63 points per 1 mg/L of URINARY fluoride (1.14 points among low-risk-of-bias studies only). THE CRITICAL NUANCE, which both sides misquote: for DRINKING WATER measured alone the inverse association held below 4 and below 2 mg/L but was NULL below 1.5 mg/L. For URINARY fluoride it stayed inverse below 1.5. The authors' own conclusion names 'limited data and uncertainty in the dose-response association ... when fluoride exposure was estimated by drinking water alone at concentrations less than 1.5 mg/L'. US fluoridation is 0.7 mg/L. So the honest sentence is: the effect is real and dose-dependent above 1.5, and at 0.7 the drinking-water evidence does not resolve it while the urinary evidence suggests it does not stop.

2. Taylor KW, Eftim SE, Sibrizzi CA, Blain RB, Magnuson K, Hartman PA, Bucher JR, Rooney AA. Addressing Critiques of the Evidence Linking Fluoride and Children's IQ.Ann Glob Health · 2025 · 91(1):8310.5334/aogh.4853 · PMID 41393310

   The NTP authors answering their critics in December 2025. Their claim here is stronger than in the JAMA paper: 'among the high-quality evidence, inverse associations were still observed at fluoride exposure levels below 1.5 mg/L, based on both urinary AND drinking-water measurements'. Quote it as their position, not as settled fact, and put it next to the JAMA abstract, which says the water-only association was null below 1.5. That gap between a team's meta-analysis and the same team's defence of it is itself worth airtime.

3. Veneri F, Vinceti M, Generali L, Giannone ME, Mazzoleni E, Birnbaum LS, Consolo U, Filippini T. Fluoride exposure and cognitive neurodevelopment: Systematic review and dose-response meta-analysis.Environ Res · 2023 · 221:11523910.1016/j.envres.2023.115239 · PMID 36639015

   The best dose-response modelling anyone has done: a cubic-spline one-stage meta-analysis of 30 studies. Highest vs lowest exposure differs by -4.68 IQ points (95% CI -6.45 to -2.92); for drinking water specifically, -5.60. The curve is substantially LINEAR above 1 mg/L — about -3.05 IQ points per 1 mg/L up to 2 mg/L, and steeper above that. Urinary fluoride shows a weaker slope starting around 0.28 mg/L, which they note corresponds to roughly 0.7 mg/L in water. AND THE LINE THAT MUST BE READ ON AIR: 'the inverse association ... was particularly strong in the studies at high risk of bias, while NO ADVERSE EFFECT emerged in the ONLY study judged at low risk of bias.' They could not rule out residual confounding.

4. Choi AL, Sun G, Zhang Y, Grandjean P. Developmental fluoride neurotoxicity: a systematic review and meta-analysis.Environ Health Perspect · 2012 · 120(10):1362–136810.1289/ehp.1104912 · PMID 22820538

   The Harvard paper that started the modern argument. 27 studies, standardised mean difference -0.45 — the identical figure the NTP would land on thirteen years later with 74 studies. Its own limitation is the one everyone forgot to mention when it went viral: these were high-fluoride endemic areas in China, comparing badly-affected villages with less-affected villages, not fluoridated cities with unfluoridated ones.

5. Grandjean P. Developmental fluoride neurotoxicity: an updated review.Environ Health · 2019 · 18(1):11010.1186/s12940-019-0551-x · PMID 31856837

   Grandjean's update, and the paper that moved the argument from ecological studies to individual exposure: three prospective cohorts from Mexico and Canada with measured maternal urinary fluoride, all negative for cognition. His benchmark-dose calculation concludes safe exposures are 'likely to be below currently accepted or recommended fluoride concentrations in drinking water'. Also makes the argument the dental literature has never answered well: topical fluoride works in the mouth, so why swallow it?

6. Kumar JV, Levy SM, Warren JJ. An update on community water fluoridation, part 2: Fluoride exposure and children's intelligence (IQ) scores.J Am Dent Assoc · 2026 · 157(5):471–48610.1016/j.adaj.2026.02.010 · PMID 41941356

   The 2026 counter-case, in the Journal of the American Dental Association. Conclusion: 'no association between F concentrations relevant to CWF and IQ', the endemic-area studies are methodologically weak, and 'there is no established biological mechanism to explain F's effect on IQ'. Two things to say about it on air, both true: the methodological critique of the Chinese cross-sectional literature is largely correct, and this is the dental profession reviewing the safety of the dental profession's flagship public health measure. Give it its argument and give it its address.

7. Kumar JV, Moss ME, Liu H, Fisher-Owens S. Association between low fluoride exposure and children's intelligence: a meta-analysis relevant to community water fluoridation.Public Health · 2023 · 219:73–8410.1016/j.puhe.2023.03.011 · PMID 37120936

   The other side's primary evidence, and it is a real analysis, not a press release. Restricted to eight studies from NON-endemic areas: SMD 0.07 (95% CI -0.02 to 0.17), I-squared 0%, no significant fluctuation across the fluoride range on spline modelling. Their honest closing sentence matters: 'the reported association observed at higher fluoride levels in endemic areas requires further investigation.' Eight studies is a small evidence base to clear a public health measure with, and they say so.

8. Gunasekaran S, Sakthivel S, Rajan RE, Balasubramanian M, Latkar YS, Mathew BM. Fluoride-induced effects on cognitive development in Indian children: A systematic review and meta-analysis.J Indian Soc Pedod Prev Dent · 2025 · 43(3):299–30610.4103/jisppd.jisppd_259_25 · PMID 41026552

   Eleven studies, 6,000-plus children, September 2025. Above 2.0 ppm the pooled effect is -6.5 IQ points (95% CI -7.3 to -5.7), worst in 6-to-10-year-olds. Useful because it is recent and specific about the exposure level; limited by the same problems as the rest — mostly cross-sectional, substantial heterogeneity, and the authors report some publication bias themselves.

9. Tang QQ, Du J, Ma HH, Jiang SJ, Zhou XJ. Fluoride and children's intelligence: a meta-analysis.Biol Trace Elem Res · 2008 · 126(1–3):115–12010.1007/s12011-008-8204-x · PMID 18695947

   The 2008 Chinese meta-analysis, sixteen case-control studies, weighted mean difference about -5 IQ points. Mostly of historical interest now, but it establishes that the signal was in the literature a full four years before Harvard found it and sixteen years before a US court did.

Fluoride & iodine

Two halogens, one transporter. The displacement story is popular, mechanistically plausible, and the best direct test of it came back negative.

1. Waugh DT. Fluoride Exposure Induces Inhibition of Sodium/Iodide Symporter (NIS) Contributing to Impaired Iodine Absorption and Iodine Deficiency.Int J Environ Res Public Health · 2019 · 16(6):108610.3390/ijerph16061086 · PMID 30917615

   The fullest statement of the displacement hypothesis, and the source most of the internet is downstream of. Proposed route: fluoride does not swap for iodine atom-for-atom, it suppresses the SODIUM-IODIDE SYMPORTER — the pump that drags iodide into the thyroid — partly by driving up TNF-alpha, IL-6, IL-1-beta, IFN-gamma and TGF-beta-1, all of which independently downregulate NIS, and partly via prolactin and megalin. IMPORTANT FOR HONESTY: this is a single-author narrative review by an environmental consultant, not primary data, and it hypothesises the mechanism rather than measuring it. It is the right place to get the hypothesis and the wrong place to stop.

2. Mudd AM, Ovando BJ, Daston GP. Probing the Biological Plausibility of Fluoride as an Endocrine Disruptor.Birth Defects Res · 2026 · 118(5):e7004610.1002/bdr2.70046 · PMID 42138003

   The direct experimental test of the displacement hypothesis, and it came back NEGATIVE. Sodium fluoride up to 300 micromolar produced NO change in iodide uptake through the sodium-iodide symporter; up to 10 micromolar it did not bind thyroid hormone receptors, did not inhibit thyroid peroxidase, and did not touch oestrogen, androgen, progesterone, PPAR, AhR, CAR, PXR, RAR or glucocorticoid receptors; up to 316 micromolar it did not alter oestrogen or testosterone synthesis. TWO THINGS MUST BE SAID TOGETHER. First: all three authors work for Procter & Gamble, which sells fluoride toothpaste, and that belongs on air in the same breath as the result. Second: the result is still the best direct measurement anyone has of this mechanism, and an in-vitro assay at fixed concentrations is not the same experiment as thirty years of drinking the stuff. Report the finding, report the funder, and do not pretend either one cancels the other.

3. Patial B, Thakur R. Exploring the Impacts of Fluoride-Induced Thyroid Toxicity: A Comprehensive Review.Biol Trace Elem Res · 2025 · 204(4):2594–261910.1007/s12011-025-04840-6 · PMID 41073679

   Reviews everything published on fluoride and the thyroid from 1976 to 2025. Reported effects: interference with iodine metabolism, lower T3 and T4, higher TSH, oxidative stress, downregulated antioxidant and thyroid genes, and histology showing follicular-cell apoptosis, necrosis and hyperplasia. Their framing — 'the thyroid gland in particular is highly susceptible to fluoride accumulation' — is worth quoting, but note that the weight of what they review is ANIMAL work at exposures well above 0.7 mg/L.

4. Peckham S, Lowery D, Spencer S. Are fluoride levels in drinking water associated with hypothyroidism prevalence in England? A large observational study of GP practice data and fluoride levels in drinking water.J Epidemiol Community Health · 2015 · 69(7):619–62410.1136/jech-2014-204971 · PMID 25714098

   The population study everyone cites: GP practices in the fully fluoridated West Midlands were nearly twice as likely to report high hypothyroidism prevalence as practices in unfluoridated Greater Manchester. It is ECOLOGICAL — practice-level, not person-level — and adjusted only for deprivation, so it cannot separate fluoride from everything else that differs between Birmingham and Manchester. Always pair it with the reply below; running it alone would be exactly the kind of one-sided citation this show exists to refuse.

5. Newton JN, Young N, Verne J, Morris J. Water fluoridation and hypothyroidism: results of this study need much more cautious interpretation.J Epidemiol Community Health · 2015 · 69(7):617–61810.1136/jech-2015-205917 · PMID 26068199

   Public Health England's response, published in the same issue. The core objection is a good one: iodine status, the actual driver of hypothyroidism, was not measured at all, and the two comparison regions differ in far more than their water. Worth reading alongside the 2017 follow-up exchange (PMID 28093451) in which neither side moves.

6. Griebel-Thompson AK, Sands S, Chollet-Hinton L, Christifano D, Sullivan DK, Hull H, Carlson SE. A Scoping Review of Iodine and Fluoride in Pregnancy in Relation to Maternal Thyroid Function and Offspring Neurodevelopment.Adv Nutr · 2023 · 14(2):317–33810.1016/j.advnut.2023.01.003 · PMID 36796438

   The most useful single sentence in this whole literature. These authors went looking for studies that measured BOTH iodine and fluoride in pregnancy — the only design that could actually test whether fluoride matters more in iodine-deficient women — and found exactly ONE. After seventy years of fluoridation and thirty years of iodine-deficiency research, one study has asked the obvious question. Their conclusion is four words long: more studies are needed.

Nano-hydroxyapatite

The fluoride-free alternative is the mineral your enamel is already made of — which is both the case for it and the reason to ask what a nanoparticle of it does elsewhere.

1. Epple M. Review of potential health risks associated with nanoscopic calcium phosphate.Acta Biomater · 2018 · 77:1–1410.1016/j.actbio.2018.07.036 · PMID 30031162

   The safety review the whole nano-hydroxyapatite question turns on, and it does not say what either camp wants. Findings: no inherent toxicity; particles taken into the cell are digested in the lysosome and raise intracellular calcium, which cells clear within hours unless the dose is very high; observed cytotoxicity in culture is mostly agglomeration and sedimentation producing a huge LOCAL dose. Crucially for toothpaste: 'there is NO RISK from an oral uptake of calcium phosphate nanoparticles due to their RAPID DISSOLUTION IN THE STOMACH' — stomach acid takes the nanoparticle apart before it can be a nanoparticle. Dermal and mucosal risk very low. The one real exposure route is INHALATION, which is an aerosol and occupational question, not a brushing question. He also names the origin of the scare: a 2016 EU SCCS statement about non-spherical nano-hydroxyapatite in cosmetics, and a 2016 US argument about nano-calcium-phosphate in baby food.

2. Cocco F, Salerno C, Wierichs RJ, Wolf TG, Arghittu A, Cagetti MG, Campus G. Hydroxyapatite-Fluoride Toothpastes on Caries Activity: A Triple-Blind Randomized Clinical Trial.Int Dent J · 2025 · 75(2):632–64210.1016/j.identj.2024.09.037 · PMID 39971658

   The largest clinical trial in this space: 610 children aged 4-7, 518 completing, 24 months, triple-blind. Hydroxyapatite-plus-fluoride pastes beat conventional monofluorophosphate pastes on enamel lesions (p<0.01); of 78 active lesions at baseline in the hydroxyapatite arm, 58 were inactive at two years. NOTE WHAT IT IS AND IS NOT: both arms contained fluoride. This trial tests hydroxyapatite as an ADDITION, not as a replacement — which is the question most people asking about it actually want answered.

3. Amaechi BT, Alshareif DO, Azees PAA, Shehata MA, Lima PP, Abdollahi A, Kalkhorani PS, Evans V, Bagheri A, Okoye LO. Anti-caries evaluation of a nano-hydroxyapatite dental lotion for use after toothbrushing: An in situ study.J Dent · 2021 · 115:10386310.1016/j.jdent.2021.103863 · PMID 34743963

   Randomised, double-blind, crossover, 30 adults wearing intra-oral appliances with real human enamel blocks. 5% nano-hydroxyapatite toothpaste remineralised early lesions and completely prevented demineralisation of sound enamel; adding a 5% lotion afterwards raised remineralisation from 37.7% to 58.4%. Real mechanism, real measurement — and an in-situ appliance study on 64 enamel blocks, which is a long way from a caries outcome in a population.

4. Butera A, Gallo S, Pascadopoli M, Montasser MA, Abd El Latief MH, Modica GG, Scribante A. Home Oral Care with Biomimetic Hydroxyapatite vs. Conventional Fluoridated Toothpaste for the Remineralization and Desensitizing of White Spot Lesions.Int J Environ Res Public Health · 2022 · 19(14):867610.3390/ijerph19148676 · PMID 35886524

   40 patients, three months, hydroxyapatite against 1450 ppm fluoride. Hydroxyapatite beat fluoride on sensitivity and pain; erosive wear scores did not move in either arm. Forty patients and one outcome that is not caries — this is a signal, not a verdict, and should be labelled that way on air.

Cancer, found and missed

Amygdalin (Laetrile)

178 patients, no benefit on any endpoint, and blood cyanide approaching the lethal range. Cochrane calls the risk-benefit balance unambiguously negative.

1. Moertel CG, Fleming TR, Rubin J, Kvols LK, Sarna G, Koch R, Currie VE, Young CW, Jones SE, Davignon JP. A clinical trial of amygdalin (Laetrile) in the treatment of human cancer.N Engl J Med · 1982 · 306(4):201–20610.1056/NEJM198201283060403 · PMID 7033783

   The trial the advocates demanded and then rejected. 178 patients, most in good general condition, a third chemotherapy-naive, given amygdalin at doses and schedules representative of actual Laetrile practice plus the full 'metabolic therapy' diet-and-enzyme programme. No benefit in cure, improvement, stabilisation, symptoms or survival. Several patients showed cyanide toxicity or blood cyanide approaching lethal. The conclusion is one sentence: a toxic drug that is not effective as a cancer treatment.

2. Milazzo S, Horneber M. Laetrile treatment for cancer.Cochrane Database Syst Rev · 2015 · 4:CD00547610.1002/14651858.CD005476.pub4 · PMID 25918920

   Eight databases, two registers, over 200 references screened across three updates — and not one study met the inclusion criteria. Zero randomised trials. The review's own verdict: the risk-benefit balance is 'unambiguously negative'. Worth noting how rare that phrasing is in a Cochrane conclusion.

Apricot seeds

Sold as a cancer cure. The active ingredient is metabolised to cyanide, and enough of it will make a pulse oximeter read a healthy man as hypoxic.

1. Konstantatos A, Shiv Kumar M, Burrell A, Smith J. An unusual presentation of chronic cyanide toxicity from self-prescribed apricot kernel extract.BMJ Case Rep · 2017 · bcr-2017-22081410.1136/bcr-2017-220814 · PMID 28893740

   A 67-year-old man looked hypoxic under routine anaesthesia. Cardiac and respiratory causes excluded, haemoglobinopathies excluded. He had been taking apricot kernel extract daily for FIVE YEARS; blood analysis confirmed cyanide toxicity, and the free cyanide was interfering with the pulse oximeter itself. Saturations normalised when he stopped. A chronic toxicity from a complementary medicine that presented as a monitoring artefact — which is exactly how these are missed.

Formalin fixation

Formaldehyde stops biology mid-sentence by cross-linking protein. It preserves shape beautifully and shreds DNA doing it.

1. Reid KM, Maistry S, Ramesar R, Heathfield LJ. A review of the optimisation of the use of formalin fixed paraffin embedded tissue for molecular analysis in a forensic post-mortem setting.Forensic Sci Int · 2017 · 280:181–18710.1016/j.forsciint.2017.09.020 · PMID 29078160

   The cost of fixation, stated without euphemism: 'The preservation of tissue in formalin is KNOWN TO DAMAGE DNA through crosslinking activity. This results in the extraction of SEVERELY FRAGMENTED DNA of variable yields, which subsequently REDUCES THE ABILITY TO PERFORM DOWNSTREAM MOLECULAR ANALYSES.' 111 studies reviewed on how to work around it. This is the single most important fact for the parasite question: the step that makes the tissue readable by eye is the same step that degrades the molecules a PCR would need to name an organism nobody suspected.

2. Matsunaga H, Arikawa K, Yamazaki M, Wagatsuma R, Ide K, Samuel AZ, Takamochi K, Suzuki K, Hayashi T, Hosokawa M, Kambara H, Takeyama H. Reproducible and sensitive micro-tissue RNA sequencing from formalin-fixed paraffin-embedded tissues for spatial gene expression analysis.Sci Rep · 2022 · 12(1):1951110.1038/s41598-022-23651-6 · PMID 36376423

   The counterweight, and the reason the episode should not end in despair. Yes, FFPE tissue 'may be severely damaged by methylene crosslinking'. But this group recovered roughly 7,000 genes from a 100-micrometre punch, 10 micrometres thick, from mouse liver fixed TWO YEARS earlier, and characterised the tumour microenvironment in human lung cancer blocks fixed SIX YEARS earlier. Every hospital in the developed world holds decades of these blocks at room temperature. The archive is readable. Nobody has read it for this.

3. Boon ME, Kok LP. Theory and practice of combining coagulant fixation and microwave histoprocessing.Biotech Histochem · 2008 · 83(6):261–27710.1080/10520290802553476 · PMID 19031284

   The history, and the reason it is formalin at all. F. Blum introduced formaldehyde as a fixative in 1893; it became standard because it hardened and preserved gross specimens, and because it was CHEAPER than the ethyl alcohol Dutch scientists had used since the eighteenth century. Alcohol-based coagulant fixatives do not cross-link, so they do not compromise immunostaining and do not damage DNA or RNA. Over 40,000 skin biopsies and 100,000 cervical samples have been processed this way in one Leiden laboratory. The authors' prediction, made in 2008 and still not realised: formalin will eventually be legislated out once health authorities 'realize that formalin invalidates expensive tests'.

H&E

Two dyes, pink and blue, unchanged since the 1870s. Almost every cancer diagnosis on earth is made on them.

1. Haghbin N, Oveisi B, Banitaba AP. Automated variable power cold microwave tissue processing: A novel universal tissue processing protocol without using formaldehyde and xylene.Acta Histochem · 2022 · 124(4):15188010.1016/j.acthis.2022.151880 · PMID 35344896

   Used here for their MAS criteria — morphology, artifacts, staining — which is the honest list of what a pathologist is actually judging when they say a slide is adequate: cellular detail, tissue arrangement, tissue integrity, stain uptake, and visual distinction under LIGHT microscopy. Every one of those criteria is about human tissue architecture. None of them asks whether something non-human is present.

2. Mewara A, Khurana S, Gupta S, Munda VS, Singh S, Sehgal R. Diagnostic performance of mini parasep solvent-free faecal parasite concentrator for the diagnosis of intestinal parasitic infections.Indian J Med Microbiol · 2019 · 37(3):381–38610.4103/ijmm.IJMM_19_44 · PMID 32003337

   The fact that breaks the simple version of the iodine story. In parasitology, IODINE MOUNT MICROSCOPY is a routine method for FINDING parasites — it is listed here alongside direct wet mount as standard practice, and the concentration methods improved the yield of Hymenolepis nana, Trichuris trichiura, Entamoeba coli and Giardia lamblia. Iodine kills protozoa and stains their nuclei so a human can identify them. In the laboratory that goes looking for parasites, iodine is the tool that reveals them. Whatever iodine does in a cancer specimen, 'makes the organism invisible' is not it.

How cancer is tested

Six steps between the tumour and the diagnosis, and every one of them was designed to answer a different question than the one a parasite would raise.

1. Haghbin N, Oveisi B, Banitaba AP. Automated variable power cold microwave tissue processing: A novel universal tissue processing protocol without using formaldehyde and xylene.Acta Histochem · 2022 · 124(4):15188010.1016/j.acthis.2022.151880 · PMID 35344896

   The cleanest plain statement of the pipeline every cancer diagnosis passes through: fixation, dehydration, clearing, paraffin infiltration, embedding, microtome slicing, staining, slide reading. Use their framing for the episode's spine, and note the two reagents they built the whole machine to avoid — formaldehyde and xylene — 'cause severe health and safety issues for humans and the environment'. The conventional protocol takes many hours; theirs takes 97 minutes. Tissue up to 4 mm thick.

2. Roh CK, Jung MJ. Laparoscopic excision for ectopic peritoneal paragonimiasis mimicking a gastric duplication cyst: A case report.Ann Med Surg (Lond) · 2021 · 69:10275410.1016/j.amsu.2021.102754 · PMID 34484726

   A 47-year-old man, no symptoms, an incidental peritoneal mass on a screening CT. Radiology called it a gastric duplication cyst. It was a lung fluke that had migrated out of the chest. The line to quote is the authors' own: 'the detection of the ova of Paragonimus parasites in sputum and BIOPSY SPECIMENS may be difficult due to an INSUFFICIENT AMOUNT.' Not because iodine destroyed it. Because there was not enough of it in the piece that was taken.

3. Al Laham O, Abdul Khalek G, Alboushi H, Abazid E, Darwish A, Hamza A. An incidentally diagnosed primary pancreatic body hydatid cyst: A case report and literature review.Int J Surg Case Rep · 2024 · 116:10939210.1016/j.ijscr.2024.109392 · PMID 38367420

   The mirror image of the episode's whole question. A 46-year-old woman with epigastric pain and a 'pancreatic body mass' on imaging went to theatre for what everybody expected to be pancreatic cancer — and lost her pancreatic body, tail and spleen. Histopathology found a hydatid cyst: a tapeworm larva. The parasite was only found BECAUSE the specimen was examined. That is the case for the pipeline, not against it, and an honest episode has to carry it.

Iodine in the specimen

Iodine reaches tissue three ways before a pathologist ever sees it, and it kills organisms on contact. Whether that is why parasites go unreported is a different question.

1. Heaselgrave W, Hamad A, Coles S, Hau S. In Vitro Evaluation of the Inhibitory Effect of Topical Ophthalmic Agents on Acanthamoeba Viability.Transl Vis Sci Technol · 2019 · 8(5):1710.1167/tvst.8.5.17 · PMID 31588380

   THE central citation for this node, and it says the thing out loud. Testing topical agents against Acanthamoeba cysts and trophozoites, povidone iodine's antiamoebic effect was 'superior to the current diamidines' — and then the clinical warning, verbatim: 'Ophthalmologists should be aware that certain topical anesthetics and ophthalmic preparations containing BAC PRIOR TO SPECIMEN SAMPLING may affect the viability of Acanthamoeba spp. IN VIVO, resulting in FALSE-NEGATIVE RESULTS IN DIAGNOSTIC TESTS.' So the mechanism is documented, in print, in a specialty that looked. NOW THE PART THAT MUST BE SAID IN THE SAME BREATH: the false negative here is in a VIABILITY test — culture. A dead organism does not grow. It is still visible under a microscope. Applying this to histopathology requires an extra step nobody has taken, which is exactly why it is worth naming as an open question rather than a finding.

2. Muthukumar V, Shi L, Chai N, Langenbucher A, Becker SL, Seitz B, Orosz E, Stachon T, Kiderlen AF, Bischoff M, Szentmáry N. Efficacy of Off-Label Anti-Amoebic Agents to Suppress Trophozoite Formation of Acanthamoeba spp. on Non-Nutrient Agar Escherichia coli Plates.Microorganisms · 2022 · 10(8):164210.3390/microorganisms10081642 · PMID 36014060

   How good an antiparasitic iodine actually is. Eight off-label anti-amoebic drugs tested against four Acanthamoeba isolates in five biological replicates. Only ONE — povidone iodine at 1% — completely suppressed trophozoite formation from drug-challenged cysts, in every isolate, every replicate. Chlorhexidine, miltefosine and dibromopropamidine mostly failed. Iodine is not a mild antiseptic that happens to be near parasites; on this evidence it is the most reliably cysticidal agent on the shelf. Surgical skin prep is 7.5-10% povidone iodine — roughly ten times the concentration tested here.

3. Padzik M, Baltaza W, Conn DB, Szaflik JP, Chomicz L. Effect of povidone iodine, chlorhexidine digluconate and toyocamycin on amphizoic amoebic strains, infectious agents of Acanthamoeba keratitis.Ann Agric Environ Med · 2018 · 25(4):725–73110.26444/aaem/99683 · PMID 30586959

   Corroborates the effect against both a clinical corneal isolate and a laboratory strain, with povidone iodine 'promising' against reference chlorhexidine. Note the co-author: David Bruce Conn of Harvard's Museum of Comparative Zoology, the same parasitologist who wrote the Hymenolepis correspondence in the New England Journal. A small field.

4. Mewara A, Khurana S, Gupta S, Munda VS, Singh S, Sehgal R. Diagnostic performance of mini parasep solvent-free faecal parasite concentrator for the diagnosis of intestinal parasitic infections.Indian J Med Microbiol · 2019 · 37(3):381–38610.4103/ijmm.IJMM_19_44 · PMID 32003337

   The necessary correction to the iodine story, kept on this node so it cannot be quoted without it. Iodine mount is a ROUTINE parasitology stain. Killing an organism and hiding an organism are different operations, and iodine performs the first while assisting the second's opposite.

Sampling error

A core needle takes about a thousandth of a tumour and the slide shows four microns of that. The arithmetic of what is never looked at.

1. Roh CK, Jung MJ. Laparoscopic excision for ectopic peritoneal paragonimiasis mimicking a gastric duplication cyst: A case report.Ann Med Surg (Lond) · 2021 · 69:10275410.1016/j.amsu.2021.102754 · PMID 34484726

   Their stated reason a fluke is missed on biopsy is not chemistry, it is arithmetic: 'insufficient amount'. And their recommendation is not a new reagent, it is a new habit — 'clinicians should bear in mind that an intra-abdominal mass may be related to a parasitic infection'. The barrier they name is the differential diagnosis, not the laboratory.

2. Tantrawatpan C, Intapan PM, Thanchomnang T, Sanpool O, Janwan P, Lulitanond V, Sadaow L, Maleewong W. Development of a PCR assay and pyrosequencing for identification of important human fish-borne trematodes and its potential use for detection in fecal specimens.Parasit Vectors · 2014 · 7:8810.1186/1756-3305-7-88 · PMID 24589167

   What is possible when somebody builds the assay. PCR plus pyrosequencing of a 46-nucleotide window in the 28S ribosomal gene distinguishes five fish-borne trematodes, and detects a SINGLE Opisthorchis viverrini or Clonorchis sinensis egg in 100 mg of stool. The authors note the reason it was needed: the eggs are 'difficult to differentiate MORPHOLOGICALLY ... even for experienced technicians'. The technology to name an organism from a few dozen bases has existed for over a decade. It is aimed at stool. It has not been aimed at tumours.

3. Matsunaga H, Arikawa K, Yamazaki M, Wagatsuma R, Ide K, Samuel AZ, Takamochi K, Suzuki K, Hayashi T, Hosokawa M, Kambara H, Takeyama H. Reproducible and sensitive micro-tissue RNA sequencing from formalin-fixed paraffin-embedded tissues for spatial gene expression analysis.Sci Rep · 2022 · 12(1):1951110.1038/s41598-022-23651-6 · PMID 36376423

   The arithmetic of the archive, and the change-my-mind study for the whole episode. A 100-micrometre punch, 10 micrometres thick — a few dozen cells — from six-year-old lung cancer blocks yielded usable sequence. The Hymenolepis case was solved by a broad eukaryotic PCR on FFPE tissue. Everything needed to ask 'is there non-human DNA in this tumour?' already exists and is already routine. Nobody has run it at scale.

Protozoa

Babesia

A malaria-like parasite that lives inside the red cell — and in sickle cell disease the cell it moves into is already failing.

1. Beri D, Rodriguez M, Singh M, McLaughlin D, Liu Y, Zhong H, Mendelson A, An X, Manwani D, Yazdanbakhsh K, Lobo CA. Babesiosis and sickle red blood cells: loss of deformability, altered osmotic fragility, and hypervesiculation.Blood · 2025 · 145(19):2202–221310.1182/blood.2024027602 · PMID 39869831

   The mechanism, measured. Using ektacytometry on AA, AS and SS red cells before and after Babesia infection, the damage lands on a spectrum: normal cells lose some deformability, sickle-trait cells more, and SS cells most of all — higher point-of-sickling values, loss of surface area, altered osmotic fragility, and hypervesiculation, shedding membrane as extracellular vesicles. That is a mechanistic explanation for why babesiosis in sickle cell disease produces hyperhaemolysis and extreme anaemia rather than the flu-like illness a healthy adult gets.

2. Cursino-Santos JR, Singh M, Senaldi E, Manwani D, Yazdanbakhsh K, Lobo CA. Altered parasite life-cycle processes characterize Babesia infection in human sickle cell anemia.Haematologica · 2019 · 104(11):2189–219910.3324/haematol.2018.214304 · PMID 30923098

   The counter-intuitive half, and the reason this topic is interesting rather than merely sad. Sickle cell TRAIT was selected because it protects against Plasmodium falciparum. So does it protect against Babesia, a close apicomplexan relative? Partly: in sickle-cell-ANAEMIA red cells the parasite does badly — defective merozoite infectivity, impaired egress, much lower parasitaemia. But sickle TRAIT cells support infection at rates comparable to normal red cells. So the trait that shields against malaria does not shield against its cousin, and the disease that limits the parasite is the same disease that cannot survive losing the cells.

3. Karkoska K, Louie J, Appiah-Kubi AO, Wolfe L, Rubin L, Rajan S, Aygun B. Transfusion-transmitted babesiosis leading to severe hemolysis in two patients with sickle cell anemia.Pediatr Blood Cancer · 2018 · 65(1)10.1002/pbc.26734 · PMID 28766838

   The clinical trap, in two cases. Babesia microti and B. duncani are transmissible by TRANSFUSION — and people with sickle cell disease are among the most transfused patients in medicine. Post-transfusion haemolysis in a sickle cell patient looks exactly like a delayed haemolytic transfusion reaction, so the reflex is steroids or other immunosuppression, which is the wrong treatment and makes the parasite worse. The authors argue for universal blood screening in endemic areas. Note for the episode: the FDA did not require region-based Babesia screening of the US blood supply until 2019.

Blastocystis

The commonest parasite in human stool — and in a 1,098-person study it tracked with BETTER glucose after meals, not worse.

1. Asnicar F, Berry SE, Valdes AM, et al. Microbiome connections with host metabolism and habitual diet from 1,098 deeply phenotyped individuals.Nat Med · 2021 · 27(2):321–33210.1038/s41591-020-01183-8 · PMID 33432175

   PREDICT 1. Deep metagenomics on 1,203 gut microbiomes against hundreds of cardiometabolic markers. Blastocystis spp. came out as an indicator of FAVOURABLE postprandial glucose metabolism, alongside Prevotella copri. A marker of a good diet is not the same as a cause — but it is the strongest single argument against treating every carrier, and it is the number to open the episode with.

Trichomonas vaginalis

Wet-mount microscopy found 26% of what PCR found in one 980-woman comparison — the commonest curable STI, missed by the test most often used.

1. Kim TG, Young MR, Goggins ER, et al. Trichomonas vaginalis in pregnancy: patterns and predictors of testing, infection, and treatment.Obstet Gynecol · 2020 · 135(5):1136–114410.1097/AOG.0000000000003776 · PMID 32282605

   3,265 pregnant women; 980 tested by BOTH wet mount and NAAT, so the comparison is within-patient. Microscopy sensitivity 26%, specificity 99% — it almost never calls a false positive and misses three quarters of the true ones. Prevalence 15%. Also worth saying on air: 29% of the retested women were positive again, which is a reinfection problem, not a drug-failure problem.

Trypanosoma cruzi

An estimated 240,000–350,000 people in the United States carry Chagas disease, and about 30% will develop heart or gut damage from it.

1. Hochberg NS, Montgomery SP. Chagas disease.Ann Intern Med · 2023 · 176(2):ITC17–ITC3210.7326/AITC202302210 · PMID 36780647

   In the Clinic review co-authored by the CDC's parasitic diseases branch. 240,000–350,000 infected in the US, mostly immigrants from endemic Latin America; transmission also by transfusion, transplant and vertically. ~30% develop cardiac or GI complications. The teaching point is that this is a US disease that is almost never screened for.

Roundworms

Strongyloides stercoralis

It completes its whole life cycle inside one host, so it persists for decades — and steroids turn that into hyperinfection with 60% ICU mortality.

1. Geri G, Rabbat A, Mayaux J, et al. Strongyloides stercoralis hyperinfection syndrome: a case series and a review of the literature.Infection · 2015 · 43(6):691–69810.1007/s15010-015-0799-1 · PMID 26008854

   133 ICU patients. 83.5% were on long-term corticosteroids; in-ICU mortality 60.3%. Two details for the episode: shock was usually driven by a concomitant gram-negative infection carried by the migrating larvae, and eosinophilia was present in only about a third — so the test people rely on is least reliable exactly when the stakes are highest.

Flukes & tapeworms

Dwarf tapeworm

In 2015 a man's tumours turned out to be the tapeworm's cancer, not his. One case, and it changed what a tumour can be.

1. Muehlenbachs A, Bhatnagar J, Agudelo CA, Hidron A, Eberhard ML, Mathison BA, Frace MA, Ito A, Metcalfe MG, Rollin DC, Visvesvara GS, Pham CD, Jones TL, Greer PW, Vélez Hoyos A, Olson PD, Diazgranados LR, Zaki SR. Malignant Transformation of Hymenolepis nana in a Human Host.N Engl J Med · 2015 · 373(19):1845–185210.1056/NEJMoa1505892 · PMID 26535513

   The case that changed what a tumour can be. A Colombian man with HIV had nests of monomorphic undifferentiated cells in lymph node and lung — invasive, crowded, cancer by every morphological criterion — except the cells were far too small to be human. A broad eukaryotic PCR returned HYMENOLEPIS NANA, the dwarf tapeworm. Immunohistochemistry and in-situ probes lit the cells up as tapeworm. Deep sequencing found structural variants in the parasite's genome 'compatible with mutations described in cancer'. So: the tapeworm's cells had become malignant, and the man was carrying a cancer that was not his. Say clearly on air that this is ONE case, in a profoundly immunosuppressed host, and that it does not show parasites cause human cancer. What it shows is narrower and stranger — that a pathologist can look at human tissue, see unambiguous cancer, and be looking at another species.

2. Conn DB. Malignant Transformation of Hymenolepis nana in a Human Host [letter].N Engl J Med · 2016 · 374(13):129310.1056/NEJMc1600490 · PMID 27028926

   The correspondence that followed, from a Harvard comparative-zoology parasitologist. Worth having because it is where the field argued about what the case actually demonstrated, and because it is a reminder that the finding survived expert scrutiny rather than being quietly dropped.

Liver flukes

Opisthorchis and Clonorchis cause bile-duct cancer and are also Group 1 carcinogens. Endemic to tens of millions of people.

1. Sivanand A, Talati D, Kalariya Y, Patel P, Gandhi SK. Associations of liver fluke infection and cholangiocarcinoma: a scoping review.Cureus · 2023 · 15(10):e4640010.7759/cureus.46400 · PMID 37927641

   Scoping review. Mechanism is specific and worth the airtime: mechanical injury from the fluke feeding in the bile duct, plus a secreted protein (OvGRN-1) taken up by human cholangiocytes that shifts gene expression toward wound-healing and cancer pathways. Note the journal — Cureus has light peer review, so verify the primary OvGRN-1 work before quoting it.

2. Kim TS, Pak JH, Kim JB, Bahk YY. Clonorchis sinensis, an oriental liver fluke, as a human biological agent of cholangiocarcinoma: a brief review.BMB Rep · 2016 · 49(11):590–59710.5483/bmbrep.2016.49.11.109 · PMID 27418285

   Names the three organisms IARC lists as Group 1 human carcinogens: Clonorchis sinensis, Opisthorchis viverrini and Schistosoma haematobium. Also the scale nobody in the West registers — C. sinensis was the most prevalent parasite in the 2012 Korean national survey at 1.86% of the general population, and it is still actively transmitted.

3. Buisson Y. [Control of Opisthorchis viverrini infection for cholangiocarcinoma prevention].Bull Soc Pathol Exot · 2017 · 110(1):61–6710.1007/s13149-017-0544-8 · PMID 28105582

   The clearest account of the mechanism, and it is three mechanisms braided: mechanical damage from adult flukes feeding on bile-duct lining for TEN TO THIRTY YEARS; chronic inflammation and oxidative stress; and mitogenic, anti-apoptotic proteins the fluke itself secretes. Plus a dietary co-factor — nitrosamines in the fermented raw fish that carries the parasite. Khon Kaen province in Thailand has the highest cholangiocarcinoma incidence on earth. Five-year survival under 5%. The detail that should end the episode's optimism: mass deworming FAILED, because people are reinfected, and repeated cure-and-reinfection cycles may themselves promote carcinogenesis.

4. Arunsan P, Ittiprasert W, Smout MJ, Cochran CJ, Mann VH, Chaiyadet S, Karinshak SE, Sripa B, Young ND, Sotillo J, Loukas A, Brindley PJ, Laha T. Programmed knockout mutation of liver fluke granulin attenuates virulence of infection-induced hepatobiliary morbidity.eLife · 2019 · 8:e4146310.7554/eLife.41463 · PMID 30644359

   The experiment that turns the association into causation. The team CRISPR-edited the granulin gene out of Opisthorchis viverrini itself — the first programmed gene knockout in a parasitic flatworm — then let the edited flukes infect hamsters. The flukes colonised the bile ducts and grew to adults normally, but the bile-duct overgrowth and fibrosis that precede cholangiocarcinoma were markedly reduced. Delete one parasite growth factor, and the pre-cancer largely does not happen. This is as close to proof of a parasite-driven cancer mechanism as the field has.

5. Feng M, Cheng X. Parasite-Associated Cancers (Blood Flukes/Liver Flukes).Adv Exp Med Biol · 2017 · 1018:193–20510.1007/978-981-10-5765-6_12 · PMID 29052139

   The compact summary of all three Group 1 organisms in one place, and blunt about the hole: the cellular and molecular mechanisms linking fluke infection to cancer 'have yet to be defined'. Also the epidemiological point that makes this a diagnosis problem as much as a biology problem — infection is frequently ASYMPTOMATIC and therefore rarely diagnosed early.

6. Maksimova GA, Zhukova NA, Kashina EV, Lvova MN, Katokhin AV, Tolstikova TG, Mordvinov VA. [Role of opisthorchis felineus on induction of bile duct cancer].Parazitologiia · 2015 · 49(1):3–11PMID 26016330

   The fourth fluke, and the one that is not on the IARC list. Opisthorchis felineus is endemic across Siberia and parts of Europe, with up to 80% infestation in endemic areas. In hamsters, infection alone produced hyperplastic and dysplastic bile-duct change; infection plus dimethylnitrosamine produced cholangiocarcinoma in EVERY animal by week 18. The authors argue their data should be used to assign it an IARC category. It still has none. That is not evidence of safety; it is evidence that nobody has run the human study.

Schistosoma haematobium

A parasite the IARC classifies as a Group 1 human carcinogen. Infection causing cancer is established science, not a fringe claim.

1. Efared B, Bako ABA, Idrissa B, et al. Urinary bladder Schistosoma haematobium-related squamous cell carcinoma: a report of two fatal cases and literature review.Trop Dis Travel Med Vaccines · 2022 · 8(1):310.1186/s40794-022-00161-x · PMID 35164874

   Two fatal cases plus review, so weak as evidence of incidence — cite it for the mechanism and the histology, not for risk figures. States S. haematobium is a proven carcinogenic agent causing bladder SQUAMOUS cell carcinoma, which is the point: a different histology from the transitional cell cancer most bladder cancer is. Needs an IARC monograph alongside it before broadcast.

2. Zaghloul MS, Zaghloul TM, Bishr MK, Baumann BC. Urinary schistosomiasis and the associated bladder cancer: update.J Egypt Natl Canc Inst · 2020 · 32(1):4410.1186/s43046-020-00055-z · PMID 33252773

   The clinical review of the one parasite-cancer link nobody disputes. Schistosoma haematobium is an IARC GROUP 1 carcinogen — the same category as tobacco and asbestos — and the cancer it causes is usually SQUAMOUS CELL carcinoma of the bladder rather than the urothelial type the West sees. Note the honest gap they name: several carcinogenic pathways have been proposed and 'the exact mechanism(s) are not defined yet'. Group 1 does not mean the mechanism is known; it means the epidemiology is beyond argument.

3. von Bülow V, Lichtenberger J, Grevelding CG, Falcone FH, Roeb E, Roderfeld M. Does Schistosoma mansoni Facilitate Carcinogenesis?Cells · 2021 · 10(8):198210.3390/cells10081982 · PMID 34440754

   The edge of the evidence, and the most useful paper for showing how IARC categories actually work. S. haematobium is Group 1 — definitely carcinogenic. S. mansoni, its close relative, is GROUP 3 — insufficient evidence to classify, which is not the same as evidence of safety. The authors argue from case reports, animal models and cell culture that mansoni may still predispose to liver and colorectal cancer. This is the honest shape of the parasite-cancer question outside the three settled organisms: a real hypothesis, a real mechanism, and a category that says nobody has done the study.

Antiparasitic drugs

Artemisinin

Pulled from a 1,600-year-old Chinese fever recipe, extracted cold because heat destroyed it, and now the backbone of malaria treatment.

1. Tu Y. The discovery of artemisinin (qinghaosu) and gifts from Chinese medicine.Nat Med · 2011 · 17(10):1217–122010.1038/nm.2471 · PMID 21989013

   Her own account, four years before the Nobel. The detail that matters for this show: the classical text said to steep the herb in cold water and wring it out, and that instruction is why the extraction worked — artemisinin degrades with heat, so the conventional hot extraction had been destroying it. The tradition did not contain the pharmacology. It contained the method, and somebody had to notice.

Ivermectin

Avermectins came out of one soil sample near a Japanese golf course and won a Nobel. The cancer claim is a real preclinical signal with no human trial behind it.

1. Robalino KN, Vivanco-Galván O, Romero-Benavides JC, Jiménez-Gaona Y. Ivermectin as an Alternative Anticancer Agent: A Review of Its Chemical Properties and Therapeutic Potential.Pharmaceuticals (Basel) · 2025 · 18(10):145910.3390/ph18101459 · PMID 41155573

   Review. States plainly that despite preclinical evidence, clinical validation remains limited. A PubMed search for human ivermectin cancer trials returned zero results on 2026-09-16.

2. Hu B, Tan H, Yu L, Liao Q, Guo W. Repurposing Ivermectin to augment chemotherapy's efficacy in osteosarcoma.Hum Exp Toxicol · 2022 · 41:960327122114369310.1177/09603271221143693 · PMID 36503300

   Cell lines and mouse xenograft. Synergy with doxorubicin. Preclinical only — this is the shape of the whole literature.

3. Bhadra S, Xu YJ. TTT (Tel2-Tti1-Tti2) Complex, the Co-Chaperone of PIKKs and a Potential Target for Cancer Chemotherapy.Int J Mol Sci · 2023 · 24(9):826810.3390/ijms24098268 · PMID 37175973

   The best answer to 'but what would it even DO?' Ivermectin binds TEL2, part of the TTT complex, which is the chaperone that folds a family of very large kinases — ATR, ATM, DNA-PKcs, mTOR, SMG1, TRRAP — the machinery of DNA-damage response and growth signalling. A HUMAN TARGET, not a worm one. That is a plausible anticancer mechanism, and it is a long way from a plausible mechanism to a treatment.

4. Hayashi A, Kamio K, Miyanaga A, Yoshida K, Noro R, Matsuda K, Tozuka T, Omori M, Hirao M, Fukuizumi A, Hisakane K, Takeuchi S, Matsumoto M, Kasahara K, Amano T, Honda K, Seike M. Ivermectin Enhances Paclitaxel Efficacy by Overcoming Resistance Through Modulation of ABCB1 in Non-small Cell Lung Cancer.Anticancer Res · 2024 · 44(12):5271–528210.21873/anticanres.17355 · PMID 39626921

   The most interesting preclinical result, because it is not about killing cells. A549 lung cancer cells made resistant to paclitaxel did it by overexpressing P-glycoprotein, the pump that throws chemotherapy back out of the cell. Giving ivermectin alongside the escalating paclitaxel ABOLISHED that P-glycoprotein induction, so the drug stayed inside and the cells never became resistant. If ivermectin has a real place in oncology, resistance-prevention alongside chemotherapy is a better hypothesis than tumour-killing on its own.

5. Shukla A, Sharma A, Gupta S, Mishra A, Singh A. Antitumor potential of ivermectin against T-cell lymphoma-bearing hosts.Med Oncol · 2025 · 42(5):16910.1007/s12032-025-02726-0 · PMID 40257544

   Representative of the preclinical literature, and useful for the number that matters. Ivermectin killed lymphoma cells with an IC50 of 10.55 micrograms per millilitre; cisplatin managed 8.32 in the same assay. The catch is the one nobody quotes: ordinary human dosing produces plasma levels of roughly 0.02-0.05 micrograms per millilitre. The concentration that kills cancer cells in a dish is two to three ORDERS OF MAGNITUDE above what a person taking ivermectin achieves. That gap is the entire story of this drug in oncology.

6. Sheir MM, El-Habashy SE, Sheta E, Nasra MMA, Abdallah OY. Biomimetic platelet-membrane camouflaged ivermectin nanocrystals for tumor homing and breast cancer management.Drug Deliv Transl Res · 2026 · 16(8):2883–291010.1007/s13346-025-02032-2 · PMID 41495333

   What serious pharmacologists do about that gap: they stop giving it as a tablet. Ivermectin nanocrystals wrapped in platelet membrane to home to tumour and evade immune clearance, active against triple-negative breast cancer in mice. Note what the authors say plainly in their own opening — repurposing ivermectin is 'hindered by poor solubility and HIGH TOXICITY, restricting its parenteral administration'. The people most invested in this drug's anticancer future are the ones building whole delivery systems to avoid giving it the way people are buying it.

7. Expression of Concern [regarding Hulscher et al., Real-world Clinical Outcomes of Ivermectin and Mebendazole in Cancer Patients: Results from a Prospective Observational Cohort].Anticancer Res · 2026 · 46(6)10.21873/anticanres.18276 · PMID 42300708

   The single most important document for this node, and it must be read on air. In 2026 Anticancer Research published a cohort reporting an 84.4% 'Clinical Benefit Ratio' for ivermectin and mebendazole in cancer patients. The journal then issued a formal Expression of Concern and opened a Post-Publication Data Integrity and Ethical Oversight Audit — examining whether IRB approval existed, whether the 197 participants' baseline cancer diagnoses can be source-verified, and whether the reported tumour regressions have objective medical documentation. The editorial board's sentence is the one to quote: 'Disclosing limitations does not exempt a clinical dataset from the foundational scientific requirements of empirical verifiability and independent ethical oversight.' This is what the strongest 'real-world evidence' for ivermectin in cancer currently amounts to.

Bacteria

H. pylori

The precedent everybody forgot: a bacterium causing ulcers and gastric cancer, dismissed for a decade, then a Nobel Prize.

1. Lee YC, Chiang TH, Chiu HM, et al. Screening for Helicobacter pylori to prevent gastric cancer: a pragmatic randomized clinical trial.JAMA · 2024 · 332(19):1642–165110.1001/jama.2024.14887 · PMID 39348147

   240,000 adults in Taiwan. The PRIMARY outcome was null: inviting people to H. pylori screening did not reduce gastric cancer incidence or mortality versus colorectal screening alone. Only a POST HOC analysis adjusting for participation and follow-up found lower incidence (0.79, 0.63–0.98) — and still no mortality benefit. Anyone citing this as proof that eradication prevents gastric cancer is citing the post-hoc number, and the episode should say which number it is using.

What is actually in the bottle

What is in a melatonin gummy

A 2023 analysis of 25 products found doses from 74% to 347% of the label, and one carried 1.3 mg of CBD that was not declared at all.

1. Cohen PA, Avula B, Wang YH, Katragunta K, Khan I. Quantity of Melatonin and CBD in Melatonin Gummies Sold in the US.JAMA · 2023 · 329(16):1401-140210.1001/jama.2023.2296 · PMID 37097362

   25 products analysed. Melatonin content ranged from 74% to 347% of the labelled amount; one product contained no detectable melatonin and 31.3 mg of CBD. Check the CBD figure against the paper before it is said aloud — reports of this study quote it both ways.

Skin

Niacinamide

It blocks pigment transfer to the keratinocyte and rebuilds ceramides. A 2015 trial also cut new skin cancers by 23% in high-risk patients — at 500 mg twice a day, oral.

1. Chen AC, Martin AJ, Choy B, et al. A Phase 3 Randomized Trial of Nicotinamide for Skin-Cancer Chemoprevention.N Engl J Med · 2015 · 373(17):1618-2610.1056/NEJMoa1506197 · PMID 26488693

   ONTRAC. 386 high-risk participants, 500 mg twice daily for 12 months: new non-melanoma skin cancers 23% lower (95% CI 4 to 38, P=0.02). Note for the episode: the confidence interval reaches almost to 4%, the trial was in an Australian high-risk population, and the benefit VANISHED once the tablets stopped. Not a general-population claim.

Oxygen & breathing

Pulse oximetry

It infers saturation from two wavelengths of light, and the dissociation curve is flat at the top — so a patient on far too much oxygen reads the same as one on exactly enough.

1. Sjoding MW, Dickson RP, Iwashyna TJ, Gay SE, Valley TS. Racial bias in pulse oximetry measurement.N Engl J Med · 2020 · 383(25):2477–247810.1056/NEJMc2029240 · PMID 33326721

   A research letter, not a full paper — worth saying when it is cited, because it changed practice at that weight. Occult hypoxaemia roughly three times more common in Black patients.

The oxygen target

Pooling 25 trials and 16,037 acutely ill adults, MORE oxygen raised in-hospital mortality by 21%. The harm appears to start around a saturation of 94 to 96 per cent.

1. Chu DK, Kim LH-Y, Young PJ, et al. Mortality and morbidity in acutely ill adults treated with liberal versus conservative oxygen therapy (IOTA): a systematic review and meta-analysis.Lancet · 2018 · 391(10131):1693–170510.1016/S0140-6736(18)30479-3 · PMID 29726345

   25 RCTs, 16,037 patients. In-hospital mortality RR 1.21 (1.03–1.43), 30-day 1.14 (1.01–1.29), longest follow-up 1.10 (1.00–1.20), I² = 0%, GRADE high. The trials span sepsis, stroke, trauma, MI and cardiac arrest — heterogeneous populations, homogeneous result, which is the striking part. The longest-follow-up CI touches 1.00.

Hydrogen & the proton

Hydrogen breath testing

Human cells make no hydrogen, so every molecule in your breath came from gut bacteria. Elegant physiology, and the weakest widely-ordered test in this atlas.

1. Rezaie A, Buresi M, Lembo A, et al. Hydrogen and methane-based breath testing in gastrointestinal disorders: the North American Consensus.Am J Gastroenterol · 2017 · 112(5):775–8410.1038/ajg.2017.46 · PMID 28323273

   Hydrogen rise ≥20 ppm by 90 minutes is positive for SIBO; methane ≥10 ppm is methane-positive. Doses: lactulose 10 g, glucose 75 g, fructose 25 g, lactose 25 g. It is a consensus statement voted by ten specialists — the thresholds are agreed, not validated against a reference standard, and the document says so.

Tin & the obesogens

Tributyltin

The most effective antifouling paint ever put on a hull, and a nanomolar agonist at the two nuclear receptors that decide whether a cell becomes a fat cell.

1. Grün F, Blumberg B. Environmental obesogens: organotins and endocrine disruption via nuclear receptor signaling.Endocrinology · 2006 · 147(6 Suppl):S50–510.1210/en.2005-1129 · PMID 16690801

   Tributyltin and triphenyltin as nanomolar agonists at RXRα/β/γ and PPARγ. A review advancing the obesogen hypothesis — the receptor pharmacology is solid, the human obesity claim is the hypothesis, and the two should not be quoted as one thing.